Abstract
The purposes of this chapter are: (1) to discuss the subjective effects and behavioral correlates, analgesia, and the tolerance and dependence-producing properties of the narcotic analgesics and to relate these changes to their abuse, (2) to review the neurophysiologic and neurochemical literature which bear upon the site and mode of action of narcotic analgesics, and (3) to speculate on the nature of the heroin abuse problem as it relates to the actions of the narcotic analgesics, as well as on areas of research which may lead to the identification of salient psychopathologic processes in the addict.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, W.J., Lorens, S.A., Mitchell, C.L.: Morphine enhances lateral hypothalamic self-stimulation in the rat. Proc. Soc. exp. Biol. (N.Y.) 140, 770–771 (1972)
Adams, W.J., Yeh, S.Y., Woods, L.A., Mitchell, C.L.: Drug-test interaction as a factor in the development of tolerance to the analgesic effect of morphine. J. Pharmacol. exp. Ther. 168, 251–257 (1969)
Adler, T.K.: The comparative potencies of codeine and its demethylated metabolites after intraventricular injection in the mouse. J. Pharmacol. exp. Ther. 140, 155–161 (1963)
Ahtee, L., Kääriäinen, I.: 5-Hydroxytryptamine in platelets and brain of rabbits treated chronically with imipramine, morphine or methadone. Naunyn-Schmiedebergs Arch. exp. Path. Pharmacok. 277, 429–436 (1973a)
Ahtee, L., Kääriäinen, I.: The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus. Europ. J. Pharmacol. 22, 206–208 (1973b)
Ahtee, L., Kääriäinen, I., Paasonen, M.K.: Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus. Ann. Med. exp. Fenn. 50, 180–185 (1972)
Akera, T., Brody, T.M.: The addiction cycle to narcotics in the rat and its relation to catecholamines. Biochem. Pharmacol. 17, 675–688 (1968)
Albus, K., Herz, A.: Inhibition of behavioural and EEG activation induced by morphine acting on lower brain-stem structures. Electroenceph. clin. Neurophysiol. 33, 537–545 (1972)
Albus, K., Schott, M., Herz, A.: Interaction between morphine and morphine antagonists after systemic and intraventricular application. Europ. J. Pharmacol. 12, 53–64 (1970)
Algeri, S., Costa, E.: Physical dependence on morphine fails to increase serotonin turnover in rat brain. Biochem. Pharmacol. 20, 877–884 (1971)
Altschul, S., Wikler, A.: Electroencephalogram during a cycle of addiction to keto-bemidone hydrochloride. Electroenceph. clin. Neurophysiol. 3, 149–153 (1951)
Amit, Z., Corcoran, M.E., Amir, S., Urca, G.: Ventral hypothalamic lesions block the consumption of morphine in rats. Life Sci. 13, 805–816 (1973)
Amsler, C.: Beiträge zur Pharmakologie des Gehirns. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 97, 1–14 (1923)
Andrews, H.L.: Brain potentials and morphine addiction. Psychosom. Med. 3, 399–409 (1941)
Andrews, H.L.: Cortical effects of demerol. J. Pharmacol. exp. Ther. 76, 89–94 (1942)
Andrews, H.L.: Changes in the electroencephalogram during a cycle of morphine addiction. Psychosom. Med. 5, 143–147 (1943)
Andrews, H.L., Himmelsbach, C.K.: Relation of the intensity of the morphine abstinence syndrome to dosage. J. Pharmacol. exp. Ther. 81, 288–293 (1944)
Aston, R.: Quantitative aspects of tolerance and posttolerance hypersensitivity to pentobarbital in the rat. J. Pharmacol. exp. Ther. 150, 253–258 (1965)
Axelrod, J.: Possible mechanism of tolerance to narcotic drugs. Science 124, 263–264 (1956)
Axelrod, J.: Cellular adaptation in the development of tolerance to drugs. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp. 247–264. Baltimore: Williams and Wilkins 1968
Axelrod, J., Cochin, J.: The inhibitory action of nalorphine on the enzymatic N-demethylation of narcotic drugs. J. Pharmacol. exp. Ther. 121, 107–112 (1957)
Ayhan, I.H.: Effect of 6-hydroxydopamine on morphine analgesia. Psychopharmacologia (Berl.) 25, 183–188 (1972)
Ayhan, I.H., Randrup, A.: Role of brain noradrenaline in morphine-induced stereotyped behaviour. Psychopharmacologia (Berl.) 27, 203–212 (1972)
Ayhan, I.H., Randrup, A.: Behavioural and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines. Psychopharmacologia (Berl.) 29, 317–328 (1973a)
Ayhan, I.H., Randrup, A.: Inhibitory effects of amphetamine, L-DOPA and apomorphine on morphine-induced behavioural excitation of rats. Arch. int. Pharmacodyn. 204, 283–292 (1973b)
Azmitia, E.C., Jr.: Tryptophan hydroxylase changes in midbrain of the rat after chronic morphine administration. Life Sci. 9, 633–637 (1970)
Bartlet, A.L.: The 5-hydroxytryptamine content of mouse brain and whole mice after treatment with some drugs affecting the central nervous system. Brit. J. Pharmacol. 15, 140–146 (1960)
Beckett, A.H., Casy, A.F., Harper, N.J.: Analgesics and their antagonists: Some steric and chemical considerations. Part III. The influence of the basic group on the biological response. J. Pharm. Pharmacol. 8, 874–883 (1956)
Bednarczyk, J.H., Smith, C.B., Sheldon, M.I., Villarreal, J.E.: Tolerance to the effects of morphine upon the incorporation of 14C-tyrosine (14C-TYR) into 14C-catecholamines (14C-CA) in mouse brain and adrenals. Pharmacologist 12, 230 (1970)
Beecher, H.K.: Measurement of subjective responses; quantitative effects of drugs. New York: Oxford University Press 1959
Beleslin, D., Polak, R.L.: Depression by morphine and chloralose of acetylcholine release from the cat’s brain. J. Physiol. (Lond.) 177, 411–419 (1965)
Beleslin, D., Polak, R.L., Sproull, D.H.: The release of acetylcholine into the cerebral subarachnoid space of anesthetized cats. J. Physiol. (Lond.) 177, 420–428 (1965)
Bell, J.A., Martin, W.R.: The effect of the narcotic antagonists naloxone, naltrexone and nalorphine on spinal cord C-fiber reflexes evoked by electrical stimulation or radiant heat. Europ. J. Pharmacol. 42, 147–154 (1977)
Berkowitz, B., Spector, S.: Evidence for active immunity to morphine in mice. Science 178, 1290–1292 (1972)
Berney, S.A., Buxbaum, D.M.: The effect of morphine on catecholamine turnover and its relationship to morphine-induced motor activity. Pharmacologist 15, 202 (1973)
Bhargava, H.N., Afifi, A.H, Way, E.L.: Effect of chemical sympathectomy on morphine antinociception and tolerance development in the rat. Biochem. Pharmacol. 22, 2769–2772 (1973)
Bhargava, H.N., Chan, S.L., Way, E.L.: Morphine analgesia, tolerance and physical dependence: Effect of intracerebral hemicholinium-3 (HC-3). Fed. Proc. 31, 527 (1972a)
Bhargava, H.N., Chan, S.L., Way, E.L.: Influence of hemicholinum (HC-3) on morphine analgesia, tolerance, physical dependence and on brain acetylcholine. Europ. J. Pharmacol. 29, 253–261 (1974)
Bhargava, H.N., Ho, I.K., Way, E.L.: Effect of dopamine beta-hydroxylase (DBH) inhibition on morphine analgesia, tolerance and physical dependence in mice. Fifth International Congress on Pharmacology, Abstracts of Volunteer Papers, p. 21, San Francisco, Calif., 1972 b
Bhargava, H.N., Way, E.L.: Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. J. Pharmacol. exp. Ther. 183, 31–40 (1972)
Biscoe, T.J., Duggan, A.W., Lodge, D.: Effect of etorphine, morphine and diprenorphrne on neurones of the cerebral cortex and spinal cord of the rat. Brit. J. Pharmacol. 46, 201–212 (1972)
Bläsig, J., Herz, A., Reinhold, K., Zieglgänsberger, S.: Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia (Berl.) 33, 19–38 (1973b)
Bläsig, J., Reinhold, K., Herz, A.: Effect of 6-hydroxydopamine,5,6-dihydroxytryptamine and raphe lesions on the antinociceptive actions of morphine in rats. Psychopharmacologia (Berl.) 31, 111–119 (1973a)
Blosser, J.C., Catravas, G.N.: Action of reserpine in morphine-tolerant rats: Absence of an antagonism of catecholamine depletion. J. Pharmacol. exp. Ther. 191, 284–289 (1974)
Bodo, R.C., Brooks, C.McC.: Effects of morphine on blood sugar and reflex activity in the chronic spinal cat. J. Pharmacol. exp. Ther. 61, 82–88 (1937)
Bonnycastle, D.D., Bonnycastle, M.F., Anderson, E.G.: The effect of a number of central depressant drugs upon brain 5-hydroxytryptamine levels in the rat. J. Pharmacol. exp. Ther. 135, 17–20 (1962)
Borison, H.L.: Influence of area postrema ablation on the emetic effect of adrenaline, apomorphine and pilocarpine administered by cerebral intraventricular injection in the cat. J. Physiol. (Lond.) 143, 14P (1958)
Borison, H.L.: Effect of ablation of medullary emetic chemoreceptor trigger zone on vomiting responses to cerebral intraventricular injection of adrenaline, apomorphine and pilocarpine in the cat. J. Physiol. (Lond.) 147, 172–177 (1959)
Borison, H.L., Fishburn, B.R., Bhide, N.K., McCarthy, L.E.: Morphine-induced hyperglycemia in the cat. J. Pharmacol. exp. Ther. 138, 229–235 (1962)
Borison, H.L., Fishburn, B.R, McCarthy, L.E.: A possible receptor role of the subfornical organ in morphine-induced hyperglycemia. Neurology (Minneap.) 14, 1049–1053 (1964)
Bosworth, D.M.: Iproniazid: A brief review of its introduction and clinical use. Ann. N.Y. Acad. Sci. 80, 809–815 (1959)
Bowers, M.B., Jr., Kleber, H.D.: Methadone increases mouse brain 5-hydroxyindoleacetic acid. Nature (Lond.) 229, 134–135 (1971)
Bowers, M.B., Jr., Kleber, H.D., Davis, L.: Acid monoamine metabolites in cerebrospinal fluid during methadone maintenance. Nature (Lond.) 232, 581–582 (1971)
Bradley, P.B.: The effects of analgesic drugs on the electrical activity of the brain. In: Soulairac, A., Cahn, J., Charpentier, J. (Eds.): Pain (Proceedings of the International Symposium on Pain, Paris, April 11–13, 1967), pp. 411–423. New York: Academic Press 1968
Bradley, P.B., Dray, A.: Actions and interactions of microiontophoretically applied morphine with transmitter substances on brain stem neurones. Brit. J. Pharmacol. 47, 642P (1973)
Brodie, B.B., Shore, P.A., Pletscher, A.: Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science 123, 992–993 (1956)
Brownlee, G., Williams, G.W.: Potentiation of amphetamine and pethidine by monoamine oxidase inhibitors. Lancet 1963I, 669
Buckett, W.R.: A new test for morphine-like physical dependence (addiction liability) in rats. Psychopharmacologia (Berl.) 6, 410–416 (1964)
Burks, T.F., Grubb, M.N.: Sites of acute morphine tolerance in intestine. J. Pharmacol. exp. Ther. 191, 518–526 (1974)
Burks, T.F., Jaquette, D.L., Grubb, M.N.: Development of tolerance to the stimulatory effect of morphine in dog intestine. Europ. J. Pharmacol. 25, 302–307 (1974)
Burks, T.F., Long, J.P.: Release of intestinal 5-hydroxytryptamine by morphine and related agents. J. Pharmacol. exp. Ther. 156, 267–276 (1967)
Busch, H., Nair, P.V., Frank, M., Martin, W.R.: Comparative pharmacological effects of a number of β-halogenated pyruvic acids. J. Pharmacol. exp. Ther. 123, 48–53 (1958)
Buxbaum, D.: Some behavioral and electrophysiological changes produced by low doses of morphine in the cat. Arch. Biol. Med. Exp. (Santiago) 4, 154 (1967)
Buxbaum, D.M, Yarbrough, G.G., Carter, M.E.: Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alterations of cerebral amine levels. J. Pharmacol. exp. Ther. 185, 317–327 (1973)
Cabanac, M.: Physiological role of pleasure. Science 173, 1103–1107 (1971)
Cahen, R.L., Wikler, A.: Effects of morphine on cortical electrical activity of the rat. Yale J. Biol. Med. 16, 239–243 (1944)
Cairnie, A.B., Kosterlitz, H.W.: The action of morphine on impulse propagation in nerve fibres. Int. J. Neuropharmacol. 1, 133–136 (1962)
Cairnie, A.B., Kosterlitz, H.W., Taylor, D.W.: Effect of morphine on some sympathetically innervated effectors. Brit. J. Pharmacol. 17, 539–551 (1961)
Calcutt, C.R., Doggett, N.S., Spencer, P.S.J.: Modification of the antinociceptive activity of morphine by centrally administered ouabain and dopamine. Psychopharmacologia (Berl.) 21, 111–117 (1971)
Calcutt, C.R., Spencer, P.S.J.: Activities of narcotic and narcotic-antagonist analgesics following the intraventricular injection of various substances. Brit. J. Pharmacol. 41, 40IP–402P (1971)
Carlsson, A., Lindqvist, M.: Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J. Pharm. Pharmacol. 21, 460–464 (1969).
Carruyo, L., Florio, V., Longo, V.G., Scotti de Carolis, A.: The effect of narcotics and narcotic-antagonists on the electrical activity of the brain: Its relationship with their pain-obtunding activity. In: Soulairac, A., Cahn, J., Charpentier, J. (Eds.): Pain (Proceedings of the International Symposium on Pain, Paris, April 11–13, 1967), pp. 425–439. New York: Academic Press 1968
Cesarman, T.: Iproniazid in cardiovascular therapy, with special reference to its action in angina pectoris and blood pressure. Ann. N.Y. Acad. Sci. 80, 988–1008 (1959)
Charpentier, J.: Variations des réponses à la douleur des rats traités par differéntes substances de type adrénergique et cholinergique. C R. Soc. Biol. (Paris) 155, 1490 (1961)
Charpentier, J.: Etude neuro-pharmacologique et électrophysiologique du comportement a la douleur chez le rat. Paris: Librairie Arnette 1965
Chen, G.: The anti-tremorine effect of some drugs as determined by Haffner’s method of testing analgesia in mice. J. Pharmacol. exp. Ther. 124, 73–76 (1958)
Cheney, D.L., Goldstein, A.: The effect of p-chlorophenylalanine on opiate-induced running, analgesia, tolerance and physical dependence in mice. J. Pharmacol. exp. Ther. 177, 309–315 (1971a)
Cheney, D.L., Goldstein, A.: Tolerance to opioid narcotics; Time course and reversibility of physical dependence in mice. Nature (Lond.) 232, 477–478 (1971b)
Cheney, D.L., Goldstein, A., Algeri, S., Costa, E.: Narcotic tolerance and dependence: Lack of relationship with serotonin turnover in the brain. Science 171, 1169–1170 (1971)
Cheney, D.L., Goldstein, A., Sheehan, P.: Rate of development and reversibility of brain tolerance and physical dependence in mice treated with opiates. Fed. Proc. 29, 685 (1970)
Chin, J.H., Crankshaw, D.P., Kendig, J.J.: Changes in the dorsal root potential with diazepam and with the analgesics aspirin, nitrous oxide, morphine and meperidine. Neuropharmacology 13, 305–315 (1974)
Chin, J.H., Domino, E.F.: Effects of morphine on brain potentials evoked by stimulation of the tooth pulp of the dog. J. Pharmacol. exp. Ther. 132, 74–86 (1961)
Chiosa, L., Dumitrescu, S., Banaru, A.: The influence of imipramine on the “abstinence syndrome” to morphine in mice. Int. J. Neuropharmacol. 7, 161–164 (1968)
Cho, T.M., Wu, Y.C., Loh, H.H., Way, E.L.: Stereospecific binding of narcotics to cerebroside sulfates. Pharmacologist 16, 248 (1974)
Christian, S.T.: Enzymes. In: Mule, S.J., Brill, H. (Eds.): Chemical and biological aspects of drug dependence, pp.449–463. Cleveland, Ohio: Chemical Rubber Co. Press 1972
Cicero, T.J.: Effects of α-adrenergic blocking agents on narcotic-induced analgesia. Arch. int. Pharmacodyn. 208, 5–13 (1974)
Cicero, T.J., Meyer, E.R.: Morphine pellet implantation in rats: Quantitative assessment of tolerance and dependence. J. Pharmacol. exp. Ther. 184, 404–408 (1973)
Cicero, T.J., Meyer, E.R., Bell, R.D.: Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat. Neuropharmacology 13, 601–607 (1974a)
Cicero, T.J., Wilcox, C.E., Meyer, E.R.: Effect of α-adrenergic blockers on naloxone-binding in brain. Biochem. Pharmacol. 23, 2349–2352 (1974b)
Cicero, T.J., Wilcox, C.E., Smithloff, B.R., Meyer, E.R., Sharpe, L.G.: Effects of morphine, in vitro and in vivo, on tryosine hydroxylase activity in rat brain. Biochem. Pharmacol. 22, 3237–3246 (1973)
Ciofalo, F.R.: Inhibition of synaptosomal 5-HT uptake by narcotics. Proc. West. Pharmacol. Soc. 16, 38 (1973)
Clouet, D.H. (ed.): Narcotic drugs; biochemical pharmacology. New York-London: Plenum Press 1971
Clouet, D.H., Neidle, A.: The effect of morphine on the transport and metabolism of intracisternally-injected leucine in the rat. J. Neurochem. 17, 1069–1074 (1970)
Clouet, D.H., Ratner, M.: Catecholamine biosynthesis in brains of rats treated with morphine. Science 168, 854–856 (1970)
Cochin, J., Axelrod, J.: Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalorphine and normorphine. J. Pharmacol. exp. Ther. 125, 105–110 (1959)
Cochin, J., Kornetsky, C.: Development and loss of tolerance to morphine in the rat after single and multiple injections. J. Pharmacol. exp. Ther. 145, 1–10 (1964)
Cohen, M., Keats, A.S., Krivoy, W., Ungar, G.: Effect of actinomycin D on morphine tolerance. Proc. Soc. exp. Biol. (NY.) 119, 381–384 (1965)
Colasanti, B., Khazan, N.: Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines. Neuropharmacology 12, 463–469 (1973a)
Colasanti, B., Khazan, N.: Agonistic properties of narcotic analgesics and antagonists on the electroencephalogram and behavior in the rat and their reversal by naloxone. Neuropharmacology 12, 619–627 (1973b)
Collier, H.O.J.: A general theory of the genesis of drug dependence by induction of receptors. Nature (Lond.) 205, 181–182 (1965)
Collier, H.O.J.: The concept of the quasi-abstinence effect and its use in the investigation of dependence mechanisms. Pharmacology 11, 58–61 (1974)
Collier, H.O.J., Francis, D.L., Schneider, C.: Modification of morphine withdrawal by drugs interacting with humoral mechanisms: Some contradictions and their interpretation. Nature (Lond.) 237, 220–222 (1972)
Collier, H.O.J., McDonald-Gibson, W.J., Saeed, S.A.: Apomorphine and morphine stimulate prostaglandin biosynthesis. Nature (Lond.) 252, 56–58 (1974)
Collier, H.O.J, Roy, A.C.: Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate. Nature (Lond.) 248, 24–27 (1974)
Contreras, E., Castillo, S., Quijada, L.: Effect of drugs that modify 3’, 5’-AMP concentrations on morphine analgesia. J. Pharm. Pharmacol. 24, 65–66 (1972)
Contreras, E., Quijada, L., Tamayo, L.: A comparative study of the effects of reserpine and p-chlorophenylalanine on morphine analgesia in mice. Psychopharmacologia (Berl.) 28, 319–324 (1973a)
Contreras, E., Tamayo, L.: Effects of drugs acting in relation to sympathetic functions on the analgesic action of morphine. Arch. int. Pharmacodyn. 160, 312–320 (1966)
Contreras, E., Tamayo, L., Quijada, L., Silva, E.: Decrease of tolerance development to morphine by 5-hydroxytryptophan and some related drugs. Europ. J. Pharmacol. 22, 339–343 (1973b)
Cook, L., Bonnycastle, D.D.: An examination of some spinal and ganglionic actions of analgetic materials. J. Pharmacol. exp. Ther. 109, 35–44 (1953)
Cools, A.R, Janssen, H.J., Broekkamp, C.L.E.: The differential role of the caudate nucleus and the linear raphé nucleus in the initiation and the maintenance of morphine-induced behaviour in cats. Arch. int. Pharmacodyn. 210, 163–174 (1974)
Corrado, A.P., Longo, V.G.: An electrophysiological analysis of the convulsant action of morphine, codeine and thebaine. Arch. int. Pharmacodyn. 132, 255–269 (1961)
Corssen, G., Domino, E.F.: Visually evoked responses in man: A method for measuring cerebral effects of preanesthetic medication. Anesthesiology 25, 330–341 (1964)
Cossio, P.: Contribution of iproniazid to the treatment of angina pectoris. Ann. N.Y. Acad. Sci. 80, 1009–1015 (1959)
Costall, B., Naylor, R.J.: A role for the amygdala in the development of the cateleptic and stereotypic actions of the narcotic agonists and antagonists in the rat. Psychopharmacologia (Berl.) 35, 203–213 (1974)
Cowan, A., Ghezzi, D., Samanin, R.: Effect of midbrain raphé lesion and of 6-hydroxydopamine on the antinociceptive action of buprenorphine in rats. Arch. int. Pharmacodyn. 208, 302–305 (1974)
Cox, B.M., Ginsburg, M., Osman, O.H.: Acute tolerance to narcotic analgesic drugs in rats. Brit. J. Pharmacol. 33, 245–256 (1968)
Cox, B.M., Opheim, K.E., Teschemacher, H., Goldstein, A.: A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci. 16, 1777–1782 (1975)
Cox, B.M., Osman, O.H.: The role of protein synthesis inhibition in the prevention of morphine tolerance. Brit. J. Pharmacol. 35, 373–374 P (1969)
Cox, B.M., Osman, O.H.: Inhibition of the development of tolerance to morphine in rats by drugs which inhibit ribonucleic acid or protein synthesis. Brit. J. Pharmacol. 38, 157 (1970)
Cox, B.M., Weinstock, M.: The effect of analgesic drugs on the release of acetylcholine from electrically stimulated guinea-pig ileum. Brit. J. Pharmacol. 27, 81–92 (1966)
Cox, C., Smart, R.G.: Social and psychological aspects of speed use-A study of types of speed users in Toronto. Int. J. Addict. 7, 201–217 (1972)
Crawford, T.B.B, Law, W.: The urinary excretion of adrenaline and noradrenaline by rats under various experimental conditions. Brit. J. Pharmacol. 13, 35–43 (1958)
Crepax, P., Infantellina, F.: Azione della morfina sul lembo isolato di corteccia cerebrale di gatto. Arch. Sci. biol. (Bologna) 40, 147–162 (1956)
Crepax, P., Infantellina, F.: Effetti dell’ applicazione locale di morfina sull’attivita elettrica del lembo isolato di corteccia cerebrale di cane predisposto ovvero non predisposto alia epilessia reflessa. Arch. Sci. biol. (Bologna) 42, 415–441 (1958)
Crossland, J., Slater, P.: The effect of some drugs on the “free” and “bound” acetylcholine content of rat brain. Brit. J. Pharmacol. 33, 42–47 (1968)
Curtis, D.R., Duggan, A.W.: The depression of spinal inhibition by morphine. Agents Actions 1, 14–19 (1969)
Curtis, D.R., Hösli, L., Johnston, G.A.R.: A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp. Brain Res. 6, 1–18 (1968)
Dabrowski, R.: Adaptation of rats to morphine. Bull. Acad. pol. Sci. Cl. 2 14, 663–666 (1966)
Dandiya, P.C., Menon, M.K.: Studies on central nervous system depressants (III). Influence of some tranquillizing agents on morphine analgesia. Arch. int. Pharmacodyn. 141, 223–232 (1963)
Datta, K., Thal, L., Wajda, I.J.: Effects of morphine on choline acetyltransferase levels in the caudate nucleus of the rat. Brit. J. Pharmacol. 41, 84–93 (1971)
Davies, J., Duggan, A.W.: Opiate agonist-antagonist effects on Renshaw cells and spinal inter-neurones. Nature (Lond.) 250, 70–71 (1974)
Davis, W.M., Brister, C.C.: Acute effects of narcotic analgesics on behavioral arousal in the rat. J. pharm. Sci. 62, 974–979 (1973)
Davis, W.M., Khalsa, J.H.: Increased shock induced aggression during morphine withdrawal. Life Sci. 10, 1321–1327 (1971)
Deanesly, R.: The histology of adrenal enlargement under experimental conditions. Amer. J. Anat. 47, 475–509 (1931)
Defalque, R.J.: Potentiation of morphine by intraperitoneal injections of iproniazid in rabbits. Anesthet. et Analg. 44, 190–193 (1965)
Deneau, G.A., Seevers, M.H.: Evaluation of new compounds for morphine-like physical dependence in the Rhesus monkey. Addendum 1, Minutes of 26th meeting of Committee on Drug Addiction and Narcotics, National Research Council, Washington, D.C. 1964
De Salva, S.J., Oester, Y.T.: The effects of central depressants on certain spinal reflexes in the acute high cervical cat. Arch. int. Pharmacodyn. 124, 255–262 (1960)
Dewey, W.L., Harris, L.S.: Antagonistic activity of morphine and other narcotics in the mouse locomotor activity test. Pharmacologist 15, 167 (1973)
Dewey, W.L, Harris, L.S., Howes, J.F., Nuite, J.A.: The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. exp. Ther. 175, 435–442 (1970)
Dhasmana, K.M., Dixit, K.S., Jaju, B.P., Gupta, M.L.: Role of central dopaminergic receptors in manic response of cats to morphine. Psychopharmacologia (Berl.) 24, 380–383 (1972)
Dole, V.P.: Biochemistry of addiction. Ann. Rev. Biochem. 39, 821–840 (1970)
Dole, V.P., Nyswander, M.E.: Methadone maintenance and its implication for theories of narcotic addiction. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp.359–366. Baltimore: Williams and Wilkins 1968
Domino, E.F.: Effects of narcotic analgesics on sensory input, activating system and motor output. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp. 117–147. Baltimore: Williams and Wilkins 1968
Domino, E.F., Wilson, A.: Effects of narcotic analgesic agonists and antagonists on rat brain acetylcholine. J. Pharmacol. exp. Ther. 184, 18–32 (1973a)
Domino, E.F., Wilson, A.E.: Enhanced utilization of bram acetylcholine during morphine withdrawal in the rat. Nature (Lond.) 243, 285–286 (1973b)
Dressier, W.E., D’Alonzo, G., Rossi, G.V., Orzechowski, R.F.: Modification of certain vascular responses to dopamine by morphine. Europ. J. Pharmacol. 28, 108–113 (1974)
Duggan, A.W., Curtis, D.R.: Morphine and the synaptic activation of Renshaw cells. Neuropharmacology 11, 189–196 (1972)
Echols, S.D., Jewett, R.E.: Effects of morphine on the sleep of cats. Pharmacologist 11, 254 (1969)
Echols, S.D, Jewett, R.E.: Effects of morphine on sleep in the cat. Psychopharmacologia (Berl.) 24, 435–448 (1972)
Eddy, N.B.: The phenomena of tolerance. In: Sevag, M.G., Reid, R.D., Reynolds, O.E. (Eds.): Origins of resistance to toxic agents, pp.223–243. New York: Academic Press 1955
Eddy, N.B, Halbach, H., Isbell, H., Seevers, M.H.: Drug dependence: Its significance and characteristics. Bull. Wld Hlth Org. 32, 721–733 (1965)
Ehrenpreis, S., Light, I., Schonbuch, G.H.: Use of the electrically stimulated guinea pig ileum to study potent analgesics. In: Singh, J.Mm., Miller, L., Lal, H. (Eds.): Drug addiction: Experimental pharmacology. Vol. 1, pp.319–342. Mount Kisco, New York: Futura Publishing Co. Inc. 1972
Eidelberg, E., Barstow, C.A.: Morphine tolerance and dependence induced by intraventricular injection. Science 174, 74–76 (1971)
Eidelberg, E., Bond, M.L.: Effects of morphine and antagonists on hypothalamic cell activity. Arch. int. Pharmacodyn. 196, 16–24 (1972)
Eidelberg, E., Erspamer, R.: Failure of naloxone to prevent acute morphine tolerance and dependence. Arch. int. Pharmacodyn. 211, 58–63 (1974)
Eidelberg, E., Schwartz, A.S.: Possible mechanism of action of morphine on brain. Nature (Lond.) 225, 1152–1153 (1970)
Eisenman, A.J., Fraser, H.F., Brooks, J.W.: Urinary excretion and plasma levels of 17-hydroxycorticosteroids during a cycle of addiction to morphine. J. Pharmacol. exp. Ther. 132, 226–231 (1961)
Eisenman, A.J., Fraser, H.F., Sloan, J.W., Isbell, H.: Urinary 17-ketosteroid excretion during a cycle of addiction to morphine. J. Pharmacol. exp. Ther. 124, 305–311 (1958)
Eisenman, A.J., Sloan, J.W., Martin, W.R., Jasinski, D.R., Brooks, J.W.: Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in man. J. psychiat. Res. 7, 19–28 (1969)
Elchisak, M.A., Rosecrans, J.A.: Effect of central catecholamine depletions by 6-hydroxydopamine on morphine antinociception in rats: Involvement of brain dopamine. Pharmacologist 15, 167 (1973)
Ellinwood, E.H.: Amphetamine psychosis: I. Description of the individuals and process. J. nerv. ment. Dis. 144, 273–283 (1967)
Elliott, T.R.: The control of the suprarenal glands by the splanchnic nerves. J. Physiol. (Lond.) 44, 374–409 (1912)
Emile, J.F., Shanaman, J., Warren, M.R.: The analgesic activity of phenelzine and other compounds. J. Pharmacol. exp. Ther. 134, 206–209 (1961)
Emmelin, N.: Supersensitivity following “pharmacological denervation”. Pharmacol. Rev. 13, 17–37 (1961)
Emmelin, N., Strömblad, R.: Adrenaline and noradrenaline content of the suprarenals of cats in chloralose and morphine-ether anesthesia. Acta. physiol. scand. 24, 261–266 (1951)
Ercoli, N., Lewis, M.N.: Studies on analgesics. I. The time-action curves of morphine, codeine, dilaudid and demerol by various methods of administration. II. Analgesic activity of acetylsalicyclic acid and aninopyrine. J. Pharmacol. exp. Ther. 84, 301–317 (1945)
Estler, C.J.: Effect of α-and β-adrenergic blocking agents and para-chlorophenylalanine on morphine-and caffeine-stimulated locomotor activity of mice. Psychopharmacologia (Berl.) 28, 261–268 (1973)
Feinberg, M.P., Cochin, J.: Inhibition of development of tolerance to morphine by cycloheximide. Biochem. Pharmacol. 22, 3082–3085 (1972)
Feldberg, W., Gupta, K.P.: Morphine hyperglycaemia; the site of action. J. Physiol. (Lond.) 224, 85P–86P (1972)
Feldberg, W., Shaligram, S.V.: The hyperglycaemic effect of morphine. Brit. J. Pharmacol. 46, 602–618 (1972)
Feldberg, W., Sherwood, S.L.: Injections of drugs into the lateral ventricle of the cat. J. Physiol. (Lond.) 123, 148–167 (1954)
Felpel, L.P., Sinclair, J.G., Yim, G.K.W.: Effects of morphine on Renshaw cell activity. Neuropharmacology 9, 203–210 (1970)
Fennessy, M.R., Lee, J.R.: Modification of morphine analgesia by drugs affecting adrenergic and tryptaminergic mechanisms. J. Pharm. Pharmacol. 22, 930–935 (1970)
Fennessy, M.R, Lee, J.R.: Comparison of the dose-response effects of morphine on brain amines, analgesia and activity in mice. Brit. J. Pharmacol. 45, 240–248 (1972)
Ferri, S., Santagostino, A., Braga, P.C., Galatulas, I.: Decreased antinociceptive effect of morphine in rats treated intraventricularly with prostaglandin E1. Psychopharmacologia (Berl.) 39, 231–235 (1974)
Fichtenberg, D.G.: Study of experimental habituation to morphine. Bull. Narcot. 3, 19–42 (1951)
Flórez, J., Delgado, G., Armijo, J.A.: Adrenergic and serotonergic mechanisms in morphine-induced respiratory depression. Psychopharmacoligia (Berl.) 24, 258–274 (1972)
Flórez, J., Delgado, G., Armijo, J.A.: Brain amines and development of acute tolerance to and dependence on morphine in the respiratory center of decerebrate cats. Neuropharmacology 12, 355–362 (1973)
Fog, R.: Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs. Psychopharmacologia (Berl.) 16, 305–312 (1970)
Foltz, E.L., White, L.E., Jr.: Experimental cingulumotomy and modification of morphine withdrawal. J. Neurosurg. 14, 655–673 (1957)
Foster, R.S., Jenden, D.J., Lomax, P.: A comparison of the pharmacologic effects of morphine and N-methyl morphine. J. Pharmacol. exp. Ther. 157, 185–195 (1967)
Fraser, H.F., Eisenman, A.J., Brooks, J.W.: Urinary excretion of 5HIAA and corticoids after morphine, meperidine, nalorphine, reserpine and chlorpromazine. Fed. Proc. 16, 298 (1957)
Fraser, H.F., Isbell, H.: Comparative effects of 20mgm. of morphine sulfate on non-addicts and former morphine addicts. J. Pharmacol. exp. Ther. 105, 498–502 (1952)
Fraser, H.F., Isbell, H.: Chlorpromazine and reserpine. (A) Effects of each and of combinations of each with morphine. (B) Failure of each in treatment of abstinence from morphine. Arch. Neurol. Psychiat. (Chic.) 76, 257–262 (1956)
Fraser, H.F., Isbell, H.: Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. Bull. Narcot. 12, 15–23 (1960)
Fraser, H.F., Wikler, A., Van Horn, G.D., Eisenman, A.J., Isbell, H.: Human pharmacology and addiction liability of normorphine. J. Pharmacol. exp. Ther. 122, 359–369 (1958)
Fraser, H.F., Van Horn, G.D., Martin, W.R., Wolbach, A.B., Isbell, H.: Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs. (B) A short-term “direct” addiction test. J. Pharmacol. exp. Ther. 133, 371–387 (1961)
Frazier, D.T., Murayama, K., Abbott, N.J., Narahashi, T.: Effects of morphine on internally perfused squid giant axons. Proc. Soc. exp. Biol. (NY.) 139, 434–438 (1972)
Frederickson, R.C.A, Pinsky, C.: Morphine impairs acetylcholine release but facilitates acetylcholine action at a skeletal neuromuscular junction. Nature (Lond.) New Biol. 231, 93–94 (1971)
Freedman, D.X., Fram, D.H., Giarman, N.J.: The effect of morphine on the regeneration of brain norepinephrine after reserpine. Fed. Proc. 20, 321 (1961)
Friebel, H., Kuhn, H.F.: Über den Nachweis von “physical dependence” bei Codein-behandelten Meerschweinchen. Med. Pharmacol. exp. 12, 92–96 (1965)
Friedler, G.: The role of immune factors in the development of tolerance to morphine. Dissertation for degree of Doctor of Philosophy, Boston University Graduate School, Boston, Massachusetts 1968
Friedler, G.: Morphine administration to male mice: Effects on subsequent progeny. Fed. Proc. 33, 515 (1974a)
Friedler, G.: Effect of pregestational morphine administration to mice on behavior of their offspring. Pharmacologist 16, 203 (1974b)
Friedler, G., Bhargava, H.N., Quock, R.; Way, E.L.: The effect of 6-hydroxy-dopamine on morphine tolerance and physical dependence. J. Pharmacol. exp. Ther. 183, 49–55 (1972)
Friedler, G., Cochin, J.: Growth retardation in offspring of female rats treated with morphine prior to conception. Science 175, 654–656 (1972)
Friend, F.J., Harris, S.C.: The effect of adrenalectomy on morphine analgesia in rats. J. Pharmacol. exp. Ther. 93, 161–167 (1948)
Fujita, S., Yasuhara, M., Ogiu, K.: Studies on sites of action of analgesics. 1. The effect of analgesics on afferent pathways of several nerves. Jap. J. Pharmacol. 3, 27–38 (1953)
Fujita, S., Yasuhara, M., Yamamoto, S., Ogiu, K.: Studies on sites of action of analgesics. 2. The effect of analgesics on afferent pathways of pain. Jap. J. Pharmacol. 4, 41–51 (1954)
Fukui, K., Shiomi, H., Takagi, H.: Effect of morphine on tyrosine hydroxylase activity in mouse brain. Europ. J. Pharmacol. 19, 123–125 (1972)
Fukui, K., Takagi, H.: Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action. Brit. J. Pharmacol. 44, 45–51 (1972)
Gaddum, J.H., Picarelli, Z.P.: Two kinds of tryptamine receptor. Brit. J. Pharmacol. 12, 323–328 (1957)
Gaddum, J.H., Vogt, M.: Some central actions of 5-hydroxytryptamine and various antagonists. Brit. J. Pharmacol. 11, 175–179 (1956)
Gangloff, H., Monnier, M.: Démonstration de l’impact des analgésiques morphiniques et d’une substance antimorphinique sur le cortex et le subcortex du lapin (thalamus, rhinencéphale et substance réticulée). Helv. physiol. pharmacol. Acta 13, C47–C48 (1955)
Gangloff, H., Monnier, M.: The topical action of morphine, levorphanol (levorphan) and the morphine antagonist levallorphan on the unanesthetized rabbit’s brain. J. Pharmacol. exp. Ther. 121, 78–95 (1957)
Gardella, J.L., Izquierdo, J.A.: The analgesic action of catecholamines and of pyrogallol. Europ. J. Pharmacol. 10, 87–90 (1970)
Gardiner, T.H., Eberhart, G.: Effects of L-trypotophan and DL-hydroxytryptophan on narcotic analgesia in mice. Fed. Proc. 29, 685 (1970)
Gauchy, C., Agid, Y., Glowinski, J., Cheramy, A.: Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum. Europ. J. Pharmacol. 22, 311–319 (1973)
Gebhart, G.F., Mitchell, C.L.: Further studies on the development of tolerance to the analgesic effect of morphine: The role played by the cylinder in the hot plate testing procedure. Arch. int. Pharmacodyn. 191, 96–103 (1971)
Gebhart, G.F., Mitchell, C.L.: The effect of adrenalectomy on morphine analgesia and tolerance development in rats. Europ. J. Pharmacol. 18, 37–42 (1972a)
Gebhart, G.F., Mitchell, C.L.: The relative contributions of the testing cylinder and the heated plate in the hot plate procedure to the development of tolerance to morphine in rats. Europ. J. Pharmacol. 18, 56–62 (1972b)
Gebhart, G.F., Mitchell, C.L.: Strain differences in the analgesic response to morphine as measured on the hot plate. Arch. int. Pharmacodyn. 201, 128–140 (1973)
Gebhart, G.F., Sherman, A.D., Mitchell, C.L.: The influence of stress on tolerance development to morphine in rats tested on the hot plate. Arch. int. Pharmacodyn. 197, 328–337 (1972)
Genovese, E., Zonta, N., Mantegazza, P.: Decreased antinociceptive activity of morphine in rats pretreated intraventricularly with 5,6-dihydroxytryptamine, a long-lasting selective depletor of brain serotonin. Psychopharmacologia (Berl.) 32, 359–364 (1973)
Gianutsos, G., Hynes, M.D., Drawbaugh, R., Lal, H.: Morphine-withdrawal aggression during protracted abstinence: Role of latent dopaminergic supersensitivity. Pharmacologist 15, 218 (1973)
Gianutsos, G., Hynes, M.D., Puri, S.K., Drawbaugh, R.B., Lal, H.: Effect of apomorphine and nigrostriatal lesions on aggression and striatal dopamine turnover during morphine withdrawal.: Evidence for dopaminergic supersensitivity in protracted abstinence. Psychopharmacologia (Berl.) 34, 37–44 (1974)
Giarman, N.J., Pepeu, G.: Drug-induced changes in brain acetylcholine. Brit. J. Pharmacol. 19, 226–234 (1962)
Gibbs, F.A., Gibbs, E.L., Lennox, W.G.: Effect on the electroencephalogram of certain drugs which influence nervous activity. Arch. intern. Med. 60, 154–166 (1937)
Gilbert, J.G., Lombardi, D.N.: Personality characteristics of young male narcotic addicts. J. cons. Psychol. 31, 536–538 (1967)
Gilbert, P.E., Martin, W.R.: The effects of morphine-and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. exp. Ther. 198, 66–82 (1976)
Goetzl, F.R., Burrill, D.Y., Ivy, A.C.: Observations on the analgesic effect of morphine during continued daily administration of small and uniform doses to dogs. J. Pharmacol. exp. Ther. 82, 110–119 (1944)
Goldstein, A., Goldstein, D.B.: Enyzme expansion theory of drug tolerance and physical dependence. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp.265–267. Baltimore: Williams and Wilkins Co. 1968
Goldstein, A., Lowney, I., Pal, B.K.: Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. nat. Acad. Sci. (Wash.) 68, 1742–1747 (1971)
Goldstein, A., Schulz, R.: Morphine-tolerant longitudinal muscle strip from guinea pig ileum. Brit. J. Pharmacol. 48, 655–666 (1973)
Goldstein, A., Sheehan, P.: Tolerance to opioid narcotics. I. Tolerance to the “running fit” caused by levorphanol in the mouse. J. Pharmacol. exp. Ther. 169, 175–184 (1969)
Goldstein, D.B., Goldstein, A.: Possible role of enzyme inhibition and repression in drug tolerance and addiction. Biochem. Pharmacol. 8, 48 (1961)
Goldstein, L., Aldunate, J.: Quantitative electroencephalographic studies on the effects of morphine and nalorphine on rabbit brain. J. Pharmacol. exp. Ther. 130, 204–211 (1960)
Goode, P.G.: An implanted reservoir of morphine solution for rapid induction of physical dependence in rats. Brit. J. Pharmacol. 41, 558–566 (1971)
Goodlet, I., Sugrue, M.F.: Effect of acutely administered analgesic drugs on rat brain serotonin turnover. Europ. J. Pharmacol. 29, 241–248 (1974)
Gorlitz, B.-D., Frey, H.-H.: Central monoamines and antinociceptive drug action. Europ. J. Pharmacol. 20, 171–180 (1972)
Grecksch, G., Ott, T., Matthies, H.: Effects of orotic acid on the development of morphine tolerance. Psychopharmacologia (Berl.) 36, 337–346 (1974)
Green, A.F., Young, P.A.: A comparison of heat and pressure analgesiometnc methods in rats. Brit. J. Pharmacol. 6, 572–587 (1951)
Gross, E.G., Holland, H., Carter, H.R., Christensen, E.M.: The role of epinephrine in analgesia. Anesthesiology 9, 459–471 (1948)
Grossman, W., Jurna, I., Nell, T., Theres, C.: The dependence of the antinociceptive effect of morphine and other analgesic agents on spinal motor activity after central monoamine depletion. Europ. J. Pharmacol. 24, 67–77 (1973)
Grumbach, L.: A hypothesis of opiate action. Presented at 23 rd meeting, Committee on Drug Addiction and Narcotics, National Research Council, New York, New York 1961
Grumbach, L.: The effect of cholinergic and cholinergic-blocking drugs on the abstinence syndrome in the rat. Fed. Proc. 28, 262 (1969)
Gunne, L.-M.: Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal. Nature (Lond.) 184, 1950–1951 (1959)
Gunne, L.-M.: The temperature response in rats during acute and chronic morphine administration. A study of morphine tolerance. Arch. int. Pharmacodyn. 129, 416–428 (1960)
Gunne, L.-M.: The excretion of noradrenaline and adrenaline in the urine of rats during chronic morphine administration and during abstinence. Psychopharmacologia (Berl.) 2, 214–220 (1961)
Gunne, L.-M.: Catecholamine metabolism and morphine abstinence. Ann. NY. Acad. Sci. 96, 205–210 (1962a)
Gunne, L.-M.: Catecholamine metabolism in morphine withdrawal in the dog. Nature (Lond.) 195, 815–816 (1962b)
Gunne, L.-M.: Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal. Acta physiol. scand. 58, Suppl. 204, pp. 1–91 (1963)
Gunne, L.-M, Jonsson, J., Fuxe, K.: Effects of morphine intoxication on brain catecholamine neurons. Europ. J. Pharmacol. 5, 338–342 (1969)
Gunne, L.-M., Jonsson, J., Fuxe, K.: Effects of chronic morphine administration on the catecholamine depletion induced by reserpine. J. Pharm. Pharmacol. 22, 550–552 (1970)
Gupta, S.K., Kulkarni, H.J.: Modification of morphine analgesia in rats by MAO inhibitors. J. Indian med. Ass. 46, 197–198 (1966)
Gyang, E.A., Kosterlitz, H.W.: Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum. Brit. J. Pharmacol. 27, 514–527 (1966)
Gyang, E.A., Kosterlitz, H.W., Lees, G.M.: The inhibition of autonomic neuroeffector transmission by morphine-like drugs and its use as a screening test for narcotic analgesic drugs. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 231–246 (1964)
Gyermek, L., Bindler, E.: Blockade of the ganglionic stimulant action of 5-hydroxytryptamine. J. Pharmacol. exp. Ther. 135, 344–348 (1962)
Haertzen, C.A.: Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol. Rep. 18, 163–194 (1966)
Haertzen, C.A., Hill, H.E., Belleville, R.E.: Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacologia (Berl.) 4, 155–166 (1963)
Haertzen, C.A., Hooks, N.T., Jr.: Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates. J. nerv. ment. Dis. 148, 606–614 (1969)
Haertzen, C.A., Panton, J.H.: Development of a “psychopathic” scale for the Addiction Research Center Inventory (ARCI). Int. J. Addict. 2, 115–127 (1967)
Hanna, C.: A demonstration of morphine tolerance and physical dependence in the rat. Arch. int. Pharmacodyn. 124, 326–329 (1960)
Hano, K., Kaneto, H., Kakunaga, T., Moribayashi, N.: Pharmacological studies of analgesics. VI. The administration of morphine and changes in acetylcholine metabolism mouse brain. Biochem. Pharmacol. 13, 441–447 (1964)
Harris, L.S.: Central neurohumoral systems involved with narcotic agonists and antagonists. Fed. Proc. 29, 28–32 (1970)
Harris, L.S., Dewey, W.L., Howes, J.F., Kennedy, J.S., Pars, H.: Narcotic-antagonist analgesics: Interactions with cholinergic substances. J. Pharmacol. exp. Ther. 169, 17–22 (1969)
Harvey, J.A., Lints, C.E.: Lesions in the medial forebrain bundle: Delayed effects on sensitivity to electric shock. Science 148, 250–252 (1965)
Harvey, J.A, Lints, C.E.: Lesions in the medial forebrain bundle: Relationship between pain sensitivity and telencephalic content of serotonin. J. comp. physiol. Psychol. 74, 28–36 (1971)
Haubrich, D.R., Blake, D.E.: Effect of acute and chronic administration of morphine on the metabolism of brain serotonin in rats. Fed. Proc. 28, 793 (1969)
Haubrich, D.R., Blake, D.E.: Modification of serotonin metabolism in rat brain after acute or chronic administration of morphine. Biochem. Pharmacol. 22, 2753–2759 (1973)
Heinrich, U., Lichtensteiger, W., Langemann, H.: Effect of morphine on the catecholamine content of midbrain nerve cell groups in rat and mouse. J. Pharmacol. exp. Ther. 179, 259–267 (1971)
Heller, B., Saavedra, J.M., Fischer, E.: Influence of adrenergic blocking agents upon morphine and catecholamine analgesic effect. Experientia (Basel) 24, 804–805 (1968)
Heller, M.E., Mordkoff, A.M.: Personality attributes of the young, nonaddicted drug abuser. Int. J. Addict. 7, 65–72 (1972)
Henderson, A., Nemes, G., Gordon, N.B., Roos, L.: Sleep and narcotic tolerance. Psychophysiology 7, 346–347 (1970)
Henderson, G., Hughes, J., Kosterlitz, H.W.: A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Brit. J. Pharmacol. 46, 764–766 (1972)
Heng, J.E., Domino, E.F.: Effects of morphine and nalorphine upon tooth pulp thresholds of dogs in the alert and drowsy state. Psychopharmacologia (Berl.) 1, 433–436 (1960)
Herken, H., Maibauer, D., Muller, S.: Acetyl cholingehalt des Gehirns und Analgesie nach Einwirkung von Morphin und einigen 3-Oxymorphinanen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 230, 313–324 (1957)
Herz, A.: Wirkungen des Arecolins auf das Zentralnervensystem. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 242, 414–429 (1962)
Herz, A., Albus, K., Metys, J., Schubert, P., Teschemacher, Hj.: On the central sites for the antinociceptive action of morphine and fentanyl. Neuropharmacology. 9, 539–551 (1970)
Herz, A., Bläsig, J., Papeschi, R.: Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats. Psychopharmacologia (Berl.) 39, 121–143 (1974)
Herz, A., Teschemacher, Hj.: Development of tolerance to the antinociceptive effect of morphine after intraventricular injection. Experientia (Basel) 29, 64–65 (1973)
Herz, A., Teschemacher, Hj., Albus, K., Zieglgänsberger, S.: Morphine abstinence syndrome in rabbits precipitated by injection of morphine antagonists into the ventricular system and restricted parts of it. Psychopharmacologia (Berl.) 26, 219–235 (1972)
Hill, H.E.: The social deviant and initial addiction to narcotics and alcohol. Quart. J. Stud. Alcohol 23, 562–582 (1962)
Hill, H.E., Haertzen, C.A., Davis, H.: An MMPI factor analytic study of alcoholics, narcotic addicts and criminals. Quart. J. Stud. Alcohol 23, 411–431 (1962)
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Jr., Miner, E.J.: The Addiction Research Center Inventory: Standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pyrahexyl and chlorpromazine. Psychopharmacologia (Berl.) 4, 167–183 (1963a)
Hill, H.E., Haertzen, C.A., Wolbach, A.B., Jr., Miner, E.J.: The Addiction Research Center Inventory: Appendix. I. Items comprising empirical scales for seven drugs. II. Items which do not differentiate placebo from any drug condition. Psychopharmacologia (Berl.) 4, 184–205 (1963b)
Hill, H.E., Haertzen, C.A., Yamahiro, R.S.: The addict physician. A Minnesota Multiphasic Personality Inventory study of the interaction of personality characteristics and availability of narcotics. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. Ment. Dis., Vol.46, pp.321–332. Baltimore: Williams & Wilkins 1968
Hill, H.E., Kornetsky, C.H., Flanary, H.G., Wikler, A.: Studies on anxiety associated with anticipation of pain. I. Effects of morphine. Arch. Neurol. Psychiat. (Chic.) 67, 612–619 (1952)
Hill, H.E., Pescor, F.T., Belleville, R.E., Wikler, A.: Use of differential bar-pressing rates of rats for screening analgesic drugs. I. Techniques and effects of morphine. J. Pharmacol. exp. Ther. 120, 388–397 (1957)
Himmelsbach, C.K.: Clinical studies of drug addiction. II. “Rossium” treatment of drug addiction. Publ. Hlth Rep. (Wash.), Suppl. 125 (1937)
Himmelsbach, C.K.: Studies of certain addiction characteristics of: (a) Dihydromorphine (“paramorphan”), (b) dihydrodesoxymorphine-D (“desomorphine”), (c) dihydrodesoxycodeine-D (“desocodeine”), (d) methyldihydromorphinone (“metopon”). J. Pharmacol. exp. Ther. 67, 239–249 (1939)
Himmelsbach, C.K.: Clinical studies of drug addiction; physical dependence, withdrawal and recovery. Arch. intern. Med. 69, 766–772 (1942)
Himmelsbach, C.K.: Morphine, with reference to physical dependence. Fed. Proc. 2, 201–203 (1943)
Himmelsbach, C.K., Andrews, H.L., Felix, R.H., Oberst, F.W., Davenport, L.F.: Studies on codeine addiction. Publ. Hlth Rep. (Wash.), Supp. 158, 1940
Himmelsbach, C.K., Gerlach, G.H., Stanton, E.J.: A method for testing addiction, tolerance and abstinence in the rat. Results of its application to several morphine alkaloids. J. Pharmacol. exp. Ther. 53, 179–188 (1935)
Hitzemann, R.J., Loh, H.H.: Effect of morphine on the transport of dopamine into mouse brain slices. Europ. J. Pharmacol. 21, 121–129 (1973)
Hitzemann, R.J., Loh, H.H., Ho, A.K.S., Way, E.L.: The effects of acute morphinization on the metabolism of 14C-tyrosine II. Proc. West. Pharmacol. Soc. 14, 91–94 (1971)
Ho, A.K.S., Loh, H.H.: Effect of morphine and amphetamine on brain cholineacetylase and esterase activity in mice and rats. Pharmacologist 12, 231 (1970)
Ho, I.K., Loh, H.H., Way, E.L.: Effect of L-tryptophan on morphine analgesia, tolerance and physical dependence. Reported to 34th meeting, Committee on Problems of Drug Dependence, National Research Council, Ann Arbor, Mich., 1972a
Ho, I.K., Loh, H.H., Way, E.L.: Effect of cyclic AMP on morphine analgesia tolerance and physical dependence. Nature (Lond.) 238, 397–398 (1972c)
Ho, I.K., Loh, H.H., Way, E.L.: Influence of 5,6-dihydroxytryptamine on morphine tolerance and physical dependence. Europ. J. Pharmacol. 21, 331–336 (1973a)
Ho, I.K., Loh, H.H., Way, E.L.: Cyclic adenosine monophosphate antagonism of morphine analgesia. J. Pharmacol. exp. Ther. 185, 336–346 (1973b)
Ho, I.K., Loh, H.H., Way, E.L.: Effects of cyclic 3’,5’-adenosine monophosphate on morphine tolerance and physical dependence. J. Pharmacol. exp. Ther. 185, 347–357 (1973c)
Ho, I.K., Loh, H.H., Way, E.L.: Influence of GABA on morphine analgesia, tolerance and physical dependence. Proc. West. Pharmacol. Soc. 16, 4–7 (1973d)
Ho, I.K., Lu, S.E., Loh, H.H., Way, E.L.: Effects of c-AMP on morphine tolerant and physically dependent mice. Pharmacologist 13, 314 (1971)
Ho, I.K., Lu, S.E., Stolman, S., Loh, H.H., Way, E.L.: Influence of p-chlorophenylalanine on morphine tolerance and physical dependence and regional brain serotonin turnover studies in morphine tolerant-dependent mice. J. Pharmacol. exp. Ther. 182, 155–165 (1972b)
Hodgson, J.R., Bristow, R.L., Castles, T.R.: Repression of RNA transcription during the development of analgesic tolerance to morphine. Nature (Lond.) 248, 671–673 (1974)
Hoeldtke, R.D., Martin, W.R.: Urine volume and catecholamine excretion. J. Lab. clin. Med. 75, 166–174 (1970)
Hoffmeister, F.: Tierexperimentelle Untersuchungen über den Schmerz und seine pharmakologische Beeinflussung. Arzneimittel-Forsch. 16. Beiheft (1968)
Hoffmeister, F., Schlichting, U.: Einfluβ von Sympathikomimetika, Sympathikolytika, Cholinomimetika und Anticholinergika auf das Abstinenzsyndrom von morphinabhängigen Ratten. In: Janzen, R., Keidel, W.D., Herz, A., Steichele, C.: Schmerz: Grundlagen — Pharmakologie — Therapie. Stuttgart: Georg Thieme Verlag 1972
Hollinger, M.: Effect of reserpine, α-methyl-p-tyrosine, p-chlorophenylalanine and pargyline on levorphanol-induced running activity in mice. Arch. int. Pharmacodyn. 179, 419–424 (1969)
Holtzman, S.G., Jewett, R.E.: Some actions of pentazocine on behavior and brain monoamines in the rat. J. Pharmacol. exp. Ther. 181, 346–356 (1972)
Holtzman, S.G., Villarreal, J.E.: Morphine dependence and body temperature in Rhesus monkeys. J. Pharmacol. exp. Ther. 166, 125–133 (1969)
Holtzman, S.G., Villarreal, J.E.: Pharmacologic analysis of the hypothermic responses of the morphine-dependent Rhesus monkey. J. Pharmacol. exp. Ther. 177, 317–325 (1971)
Horlington, M., Lockett, M.F.: Antagonism between alkylated and norcompounds of the morphine group injected intracisternally into mice. J. Pharm. Pharmacol. 11, 415–420 (1959)
Hosoya, E.: Some withdrawal symptoms of rats to morphine. Pharmacologist 1, 77 (1959)
Houde, R.W., Wikler, A.: Delineation of the skin-twitch response in dogs and the effects thereon of morphine, thiopental and mephenesin. J. Pharmacol. exp. Ther. 103, 236–242 (1951)
Houde, R.W., Wikler, A., Irwin, S.: Comparative actions of analgesic, hypnotic and paralytic agents on hindlimb reflexes in chronic spinal dogs. J. Pharmacol. exp. Ther. 103, 243–248 (1951)
Howes, J.F., Harris, L.S., Dewey, W.L.: The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro. Arch. int. Pharmacodyn. 184, 267–276 (1970)
Howes, J.F., Harris, L.S., Dewey, W.L., Voyda, C.A.: Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. J. Pharmacol. exp. Ther. 169, 23–28 (1969)
Hughes, J.: Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 88, 295–308 (1975)
Hughes, J., Smith, T., Morgan, B., Fothergill, L.: Purification and properties of encephalin-the possible endogenous ligand for the morphine receptor. Life Sci. 16, 1753–1758 (1975)
Huidobro, F.: Effects of some indoles and acridine derivatives on the analgesic effect of morphine. Acta physiol. lat.-amer. 13, 71–72 (1963)
Huidobro, F.: Morphine dependence in mice. Arch. Biol. Med. Exp. (Santiago) 4, 155–161 (1967)
Huidobro, F.: Some relations between tolerance and physical dependence to morphine in mice. Europ. J. Pharmacol. 15, 79–84 (1971)
Huidobro, F., Contreras, E., Croxatto, R.: Studies on morphine.-III. Action of metabolic precursors to serotonin and noradrenaline and related substances on the “abstinence syndrome” to morphine on white mice. Arch. int. Pharmacodyn. 146, 444–454 (1963a)
Huidobro, F., Contreras, E., Croxatto, R.: Studies on morphine.-IV. Effects of some metabolites on the “abstinence syndrome” to morphine on white mice. Arch. int. Pharmacodyn. 146, 455–462 (1963b)
Huidobro, F., Huidobro, J.P., Larrain, G.: Tolerance to morphine in the white mice. Acta physiol. lat.-amer. 18, 59–67 (1968)
Huidobro, J.P., Huidobro, F.: Acute morphine tolerance in newborn and young rats. Psychopharmacologia (Berl.) 28, 27–34 (1973)
Ireson, J.D.: Opioid and muscarinic anti-nociception. Brit. J. Pharmacol. 37, 504P–505P (1969)
Irwin, S., Houde, R.W., Bennett, D.R., Hendershot, L.C., Seevers, M.H.: The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. exp. Ther. 101, 132–143 (1951)
Isbell, H.: The addiction liability of some derivatives of meperidine. J. Pharmacol. exp. Ther. 97, 182–189 (1949)
Isbell, H., Eisenman, A.J., Wikler, A., Frank, K.: The effects of single doses of 6-dimethylamino-4-4-diphenyl-3-heptanone (amidone, methadon or “10820”) on human subjects. J. Pharmacol. exp. Ther. 92, 83–89 (1948a)
Isbell, H., Wikler, A., Eisenman, A.J., Daingerfield, M., Frank, K.: Liability of addiction to 6-dimethylamino-4,4-diphenyl-3-heptanone (methadon, “amidone” or “10820”) in man. Arch. intern. Med. 82, 362–392 (1948b)
Isbell, H., Wikler, A., Eisenman, A.J., Frank, K.: Effect of single doses of 10820 (4,4-diphenyl-6-dimethylamino-heptanone-3) in man. Fed. Proc. 6, 341 (1947)
Ivy, A.C., Goetzl, F.R., Harris, S.C., Burrill, D.Y.: The analgesic effect of intracarotid and intravenous injection of epinephrine in dogs and of subcutaneous injection in man. Quart. Bull. Northw. Univ. med. Sch. 18, 298–306 (1944)
Iwamoto, E.T., Ho, I.K., Way, E.L.: Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats. J. Pharmacol. exp. Ther. 187, 558–567 (1973)
Iwamoto, E.T., Shen, F., Loh, H.H., Way, E.L.: The effects of pargyline on morphine tolerant-dependent mice. Fed. Proc. 30, 278 (1971)
Jacquet, Y.F., Lajtha, A.: Morphine action at central nervous system sites in rat: Analgesia or hyperalgesia depending on site and dose. Science 182, 490–492 (1973)
Jaffe, J.H., Sharpless, S.K.: The rapid development of physical dependence on barbiturates. J. Pharmacol. exp. Ther. 150, 140–145 (1965)
Jasinski, D.R., Martin, W.R., Haertzen, C.A.: The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J. Pharmacol. exp. Ther. 157, 420–426 (1967)
Jasinski, D.R., Martin, W.R., Hoeldtke, R.: Studies of the dependence-producing properties of GPA-1657, profadol, and propiram in man. Clin. Pharmacol. Ther. 12, 613–649 (1971)
Jasinski, D.R., Nutt, J.G., Bunney, W.E.: Lithium: Lack of effect on morphine euphoria. Pharmacologist 15, 168 (1973)
Jhamandas, K.: Effect of morphine and its antagonists on the release of cortical acetylcholine (ACh) in the normal and morphine dependent rats. Pharmacologist 15, 202 (1973)
Jhamandas, K., Dickinson, G.: Modification of precipitated morphine and methadone abstinence in mice by acetylcholine antagonists. Nature (Lond.) New Biol. 245, 219–221 (1973)
Jhamandas, K., Phillis, J.W., Pinsky, C.: Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat. Brit. J. Pharmacol. 43, 53–66 (1971)
Jhamandas, K., Pinsky, C., Phillis, J.W.: Effects of morphine and its antagonists on release of cerebral cortical acetylcholine. Nature (Lond.) 228, 176–177 (1970)
Joël, E., Ettinger, A.: Zur Pathologie der Gewöhnung. III. Mitteilung: Experimentelle Studien liber Morphingewöhnung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 115, 334–350 (1926)
Johannesson, T., Long, J.P.: Acetylcholine in the brain of morphine tolerant and non-tolerant rats. Acta pharmacol. (Kbh.) 21, 192–196 (1964)
Jones, B.E., Martin, W.R., Jasinski, D.R.: Skin conductance responses to hypercapnia in man during a cycle of addiction to morphine. Psychopharmacologia (Berl.) 14, 394–403 (1969)
Jounela, A.J., Mattila, M.J.: Modification by phenelzine of morphine and pethidine analgesia in mice. Ann. Med. exp. Fenn. 46, 66–71 (1968)
Jurna, I.: The effect of morphine on the discharge of muscle spindles with intact motor innervation. Int. J. Neuropharmacol. 4, 177–183 (1965)
Jurna, I.: Inhibition of the effect of repetitive stimulation on spinal motoneurones of the cat by morphine and pethidine. Int. J. Neuropharmacol. 5, 117–123 (1966)
Jurna, I., Grossmann, W., Theres, C.: Inhibition by morphine of repetitive activation of cat spinal motoneurones. Neuropharmacology 12, 983–993 (1973)
Jurna, I., Schafer, H.: Depression of post-tetanic potentiation in the spinal cord by morphine and pethidine. Experientia (Basel) 21, 226–227 (1965)
Jurna, I., Schlue, W.R., Tamm, U.: The effect of morphine on primary somatosensory evoked responses in the rat cerebral cortex. Neuropharmacology 11, 409–415 (1972)
Kamei, C., Shimomura, K., Ueki, S.: Significance of withdrawal jumping response in predicting physical dependence in mice. Jap. J. Pharmacol. 23, 421–426 (1973)
Karr, W.G., Light, A.B., Torrance, E.G.: Opium addiction. IV.The blood of the human addict during the administration of morphine. In: Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, W.A.: Opium addiction, pp.33–39. Chicago, Illinois: American Medical Assn. 1929-30. (Reprinted from Arch. intern. Med., Vols. 43–44)
Kay, D.C., Eisenstein, R.B., Jasinski, D.R.: Morphine effects on human REM state, waking state and NREM sleep. Psychopharmacologia (Berl.) 14, 404–416 (1969)
Kay, D.C., Kelly, O.A.: Some changes in human sleep during chronic intoxication with morphine. Psychophysiology 7, 346 (1970)
Kayan, S., Ferguson, R.K., Mitchell, C.L.: An investigation of pharmacologic and behavioral tolerance to morphine in rats. J. Pharmacol. exp. Ther. 185, 300–306 (1973)
Kayan, S., Mitchell, C.L.: The effects of chronic morphine administration on tooth pulp thresholds in dogs and cats. Proc. Soc. exp. Biol. (N.Y.) 128, 755–760 (1968)
Kayan, S., Woods, L.A., Mitchell, C.L.: Experience as a factor in the development of tolerance to the analgesic effect of morphine. Europ. J. Pharmacol. 6, 333–339 (1969)
Kaymakcalan, S., Woods, L.A.: Nalorphine-induced “abstinence syndrome” in morphine-tolerant albino rats. J. Pharmacol. exp. Ther. 117, 112–116 (1956)
Keele, C.A., Armstrong, D.: Substances producing pain and itch. Baltimore: Williams & Wilkins, 1964
Keranen, G.M., Zaratzian, V.L., Coleman, R.: Studies on 1,4-dipyrrolidino-2-butyne (Tremorine) in mice. Toxicol. appl. Pharmacol. 3, 481–492 (1961)
Kerr, F.W.L., Pozuelo, J.: Suppression of physical dependence and induction of hypersensitivity to morphine by stereotaxic hypothalamic lesions in addicted rats. Mayo Clin. Proc. 46, 653–665 (1971)
Kerr, F.W.L., Triplett, J.N., Jr., Beeler, G.W.: Reciprocal (push-pull) effects of morphine on single units in the ventromedian and lateral hypothalamus and influences on other nuclei: With a comment on methadone effects during withdrawal from morphine. Brain Res. 74, 81–103 (1974)
Khalsa, J.H., Davis, W.M.: Effects of chronic alpha-methyltyrosine on the locomotor activity response to morphine and amphetamine in rats. Pharmacologist 15, 219 (1973)
Khazan, N., Colasanti, B.: Differential pharmacodynamics of morphine injection in naive and post-addict rats. Fed. Proc. 30, 277 (1971a)
Khazan, N., Colasanti, B.: Decline in the mean integrated electroencephalogram voltage during morphine abstinence in the rat. J. Pharmacol. exp. Ther. 177, 491–499 (1971b)
Khazan, N., Colasanti, B.: EEG correlates of morphine challenge in postaddict rats. Psychopharmacologia (Berl.) 22, 56–63 (1971c)
Khazan, N., Colasanti, B.: Protracted rebound in rapid eye movement sleep time and electroencephalogram voltage output in morphine-dependent rats upon withdrawal. J. Pharmacol. exp. Ther. 183, 23–30 (1972)
Khazan, N., Roehrs, T.: EEG responses to morphine test dose in morphine-and methadonetreated rats. Pharmacologist 15, 168 (1973)
Khazan, N., Sawyer, C.H.: Mechanisms of paradoxical sleep as revealed by neurophysiologic and pharmacologic approaches in the rabbit. Psychopharmacologia (Berl.) 5, 457–466 (1964)
Khazan, N., Weeks, J.R., Schroeder, L.A.: Electroencephalographic, electromyographic and behavioral correlates during a cycle of self-maintained morphine addiction in the rat. J. Pharmacol. exp. Ther. 155, 521–531 (1967)
Killam, K.F., Deneau, G.A.: A study of morphine dependence in four species of subhuman primates. Proc. West. Pharmacol. Soc. 16, 1–3 (1973)
Kiplinger, G.F., Clift, J.W.: Pharmacological properties of morphine-potentiating serum obtained from morphine-tolerant dogs and men. J. Pharmacol. exp. Ther. 146, 139–146 (1964)
Klee, W., Streaty, R.A.: Narcotic receptor sites in morphine-dependent rats. Nature (Lond.) 248, 61–63 (1974)
Knapp, S, Mandell, A.J.: Narcotic drugs: Effects on the serotonin biosynthetic systems of the brain. Science 177, 1209–1211 (1972)
Kolb, L.: Pleasure and deterioration from narcotic addiction. Ment. Hyg. (N.Y.) 9, 699–724 (1925)
Kolb, L., DuMez, A.G.: Experimental addiction of animals to opiates. Publ. Hlth Rep. (Wash.) 46, 698–726 (1931)
Kolb, L., Himmelsbach, C.K.: Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Publ. Hlth Rep. (Wash.), Suppl. 128 (1938)
Koll, W., Haase, J., Block, G., Mühlberg, B.: The predilective action of small doses of morphine on nociceptive spinal reflexes of low spinal cats. Int. J. Pharmacol. 2, 57–65 (1963)
Korf, J., Bunney, B.S., Aghajanian, G.K.: Noradrenergic neurons: Morphine inhibition of spontaneous activity. Europ. J. Pharmacol. 25, 165–169 (1974)
Kornetsky, C., Cochin, J.: Evidence of tolerance to morphine in the mouse after injection of serum from morphine-tolerant rabbits. Fed. Proc. 23, 283 (1964)
Kornetsky, C., Kiplinger, G.F.: Potentiation of an effect of morphine in the rat by sera from morphine-tolerant and abstinent dogs and monkeys. Psychopharmacologia (Berl.) 4, 66–71 (1963)
Kosterlitz, H.W., Lord, J.A.H., Watt, A.J.: Morphine receptor in the myenteric plexus of the guinea pig ileum. In: Kosterlitz, H.W., Collier, H.O.J., Villarreal, J.E. (Eds.): Agonist and antagonist actions of narcotic analgesic drugs (Proceedings of the symposium of the British Pharmacological Society, Aberdeen, July 1971). pp.45–61. London: Macmillan Press, 1972
Kosterlitz, H.W., Robinson, J.A.: Inhibition of the peristaltic reflex of the isolated guinea pig ileum. J. Physiol. (Lond.) 136, 249–262 (1957)
Kosterlitz, H.W., Robinson, J.A.: The inhibitory action of morphine on the contraction of the longitudinal muscle coat of the isolated guinea pig ileum. Brit. J. Pharmacol. 13, 296–303 (1958)
Kosterlitz, H.W., Taylor, D.W.: The effect of morphine on vagal inhibition of the heart. Brit. J. Pharmacol. 14, 209–214 (1959)
Kosterlitz, H.W., Wallis, D.L.: The action of morphine-like drugs on impulse transmission in mammalian nerve fibres. Brit. J. Pharmacol. 22, 499–510 (1964)
Kosterlitz, H.W., Wallis, D.I.: The effects of hexamethonium and morphine on transmission in the superior cervical ganglion of the rabbit. Brit. J. Pharmacol. 26, 334–344 (1966)
Kosterlitz, H.W., Watt, A.J.: Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Brit. J. Pharmacol. 33, 266–276 (1968)
Krivoy, W.A.: The action of analgetic agents on positive afterpotentials of frog sciatic nerve. J. Pharmacol. exp. Ther. 129, 186–190 (1960)
Krivoy, W.A., Huggins, R.A.: The action of morphine, methadone, meperidine and nalorphine on dorsal root potentials of cat spinal cord. J. Pharmacol. exp. Ther. 134, 210–213 (1961)
Krivoy, W., Kroeger, D., Zimmermann, E.: Actions of morphine on the segmental reflex of the decerebrate spinal cat. Brit. J. Pharmacol. 47, 457–464 (1973)
Krivoy, W., Kroeger, D., Taylor, A.N., Zimmermann, E.: Antagonism of morphine by β-melanocyte-stimulating hormone and by tetracosactin. Europ. J. Pharmacol. 27, 339–345 (1974b)
Krivoy, W., Zimmermann, E., Lande, S.: Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine vasopressin (DGVP). Proc. nat. Acad. Sci. (Wash.), 71 1852–1856 (1974a)
Krueger, H., Eddy, N.B., Sumwalt, M.: The pharmacology of the opium alkaloids, Part 1. Publ. Hlth Rep. (Wash.), Suppl. 165 (1941)
Krueger, H., Eddy, N.B., Sumwalt, M.: The pharmacology of the opium alkaloids, Part 2. Publ. Hlth Rep. (Wash.), Suppl. 165 (1943)
Kruglov, N.A.: Influence of analgesic substances on the lability and some other functional characteristics of the nerve center [in Russian]. Doctor’s Thesis, Leningrad, 1955, p. 210
Kruglov, N.A.: Influence of some analgesic and narcotic substances on reciprocal inhibition [in Russian]. Pharmacol. Toxicol. 22, 488–493 (1959)
Kruglov, N.A.: Effect of the morphine-group analgesics on the central inhibitory mechanisms. Int. J. Neuropharmacol. 3, 197–203 (1964)
Kuhn, H.-F, Friebel, H.: Über den Nachweis von “physical dependence” bei Codein-behandelten Ratten. Med. exp. 6, 301–306 (1962)
Kumar, R., Mitchell, E., Stolerman, I.P.: Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Brit. J. Pharmacol. 42, 473–484 (1971)
Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in the rat: Relation to striatal dopamine metabolism. Europ. J. Pharmacol. 19, 119–122 (1972)
Labrecque, G., Domino, E.F.: Tolerance to and physical dependence on morphine: Relation to neocortical acetylcholine release in the cat. J. Pharmacol. exp. Ther. 191, 189–200 (1974)
Lal, H., O’Brien, J., Puri, S.K.: Morphine-withdrawal aggression: Sensitization by amphetamines. Psychopharmacologia (Berl.) 22, 217–223 (1971a)
Lal, H., Puri, S.K: Morphine-withdrawal aggression: Role of dopaminergic stimulation. In: Singh, J.M., Miller, L., Lal, H. (Eds.): Drug addiction: Experimental pharmacology, Vol.1, pp. 301–310. Mount Kisco, N.Y.: Futura Publishing Co. 1972
Lal, H., Puri, S.K.: Effect of acute morphine or haloperidol administration on catalepsy and striatal dopamine turnover in rats chronically treated with morphine or haloperidol. Pharmacologist 15, 259 (1973)
Lal, H., Puri, S.K., Karkalas, Y.: Blockade of opioid-withdrawal symptoms by haloperidol in rats and humans. Pharmacologist 13, 263 (1971b)
Landmesser, C.M., Cobb, S., Converse, J.G.: Effects of N-allylnormorphine upon the respiratory depression due to morphine in anesthetized man with studies on the respiratory response to carbon dioxide. Anesthesiology 14, 535–549 (1953)
Large, W.A., Milton, A.S.: The effect of acute and chronic morphine administration on brain acetylcholine levels in the rat. Brit. J. Pharmacol. 38, 451P–452P (1970)
Large, W.A., Milton, A.S.: Effects of morphine, levorphanol, nalorphine and naloxone on the release of acetylcholine from slices of rat cerebral cortex and hippocampus. Brit. J. Pharmacol. 41, 398P (1971)
Lasagna, L., von Felsinger, J.M., Beecher, H.K.: Drug-induced mood changes in man. 1. Observations on healthy subjects, chronically ill patients, and “postaddicts.” J. Amer. med. Ass. 157, 1006–1020 (1955)
Laverty, R., Sharman, D.F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit. J. Pharmacol. 24, 759–772 (1965)
Lavikainen, P., Mattila, M.: The convulsions and the brain acetylcholine metabolism after morphine and nalorphine. Ann. Med. exp. Fenn. 37, 133–140 (1959)
Lee, C.Y., Stolman, S., Akera, T., Brody, T.M.: Saturable binding of (3H)-dihydromorphine to rat brain tissue in vitro: characterization and effect of morphine pretreatment. Pharmacologist 15, 202 (1973)
Lee, J.R., Fennessy, M.R.: The relationship between morphine analgesia and the levels of biogenic amines in the mouse brain. Europ. J. Pharmacol. 12, 65–70 (1970)
Leimdorfer, A.: An electroencephalographic analysis of the action of amidone, morphine, and strychnine on the central nervous system. Arch. int. Pharmacodyn. 76, 153–162 (1948)
Leimdorfer, A.: The action of sympathomimetic amines on the central nervous system and the blood sugar: Relation of chemical structure to mechanism of action. J. Pharmacol. exp. Ther. 98, 62–71 (1950)
Leimdorfer, A., Arana, R., Hack, M.H.: Hyperglycemia induced by the action of adrenalin on the central nervous system. Amer. J. Physiol. 150, 588–595 (1947)
Leimdorfer, A., Metzner, W.R.T.: Analgesia and anesthesia induced by epinephrine. Amer. J. Physiol. 157, 116–121 (1949)
Leme, J.G., Rocha E Silva, M.: Analgesic action of chlorpromazine and reserpine in relation to that of morphine. J. Pharm. Pharmacol. 13, 734–742 (1961)
Leslie, G.B.: The effect of anti-parkinsonian drugs on oxotremonne-induced analgesia in mice. J. Pharm. Pharmacol. 21, 248–250 (1969)
Lewis, J.R.: Tolerance in rats to new synthetic analgesic drugs. Fed. Proc. 8, 315 (1949)
Lewis, S.A., Oswald, I., Evans, J.I., Akindele, M.O., Tompsett, S.L.: Heroin and human sleep. Electroenceph. clin. Neurophysiol. 28, 374–381 (1970)
Light, A.B., Torrance, E.G.: Opium addiction. II. Physical characteristics and physical fitness of addicts during administration of morphine. In: Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, 1W.A.: Opium addiction, pp.13–20. Chicago: American Medical Assn. 1929-30a. (Reprinted from Arch. intern. Med., Vols. 43–44)
Light, A.B., Torrance, E.G.: Opium addiction. III. The circulation and respiration of human addicts during the administration of morphine. In: Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, W.A.: Opium addiction, pp.21–32. Chicago: American Medical Assn. 1929-30b. (Reprinted from Arch. intern. Med., Vols. 43–44)
Light, A.B., Torrance, E.G.: Opium addiction. V. Miscellaneous observations on human addicts during the administration of morphine. In: Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, W.A.: Opium addiction, pp.40–50. Chicago: American Medical Assn., 1929-30c. (Reprinted from Arch. intern. Med., Vols. 43–44)
Light, A.B., Torrance, E.G.: Opium addiction. VI. The effects of abrupt withdrawal followed by readministration of morphine in human addicts, with special reference to the composition of the blood, the circulation and the metabolism. In: Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, W.A.: Opium addiction, pp.51–66. Chicago, American Medical Assn., 1929-30d. (Reprinted from Arch. intern. Med., Vols. 43–44)
Light, A.B., Torrance, E.G., Karr, W.G., Fry, E.G., Wolff, W.A.: Opium addiction. Chicago: American Medical Assn., 1929-30. (Reprinted from Arch. intern. Med., Vols. 43–44)
Lim, R.K.S.: Visceral receptors and viscera pain. Ann. N. Y. Acad. Sci. 86, 73–89 (1960)
Lim, R.K.S, Guzman, F.: Manifestations of pain in analgesic evaluation in animals and man. In: Soulairac, A., Cahn, J., Charpentier, J. (Eds.): Pain (Proceedings of the International Symposium on Pain, Paris, April 11–13, 1967), pp.119–152, New York: Academic Press 1968
Lin, S.C., Sutherland, V.C., Way, E.L.: Brain amino acids in morphine tolerant and non-tolerant rats. Proc. West. Pharmacol. Soc. 16, 8–13 (1973)
Lints, C.E., Harvey, J.A.: Altered sensitivity to foot-shock and decreased brain content of serotonin following brain lesions in the rat. J. comp. physiol. Psychol. 67, 23–31 (1969)
Little, H.J., Rees, J.M.H.: Tolerance development to the antinociceptive actions of morphine, amphetamine, physostigmine and 2-aminoindane in the mouse. Experientia (Basel) 30, 930–932 (1974)
Lockett, M.F., Davis, M.M.: The analgesic action of normorphine administered intracisternally to mice. J. Pharm. Pharmacol. 10, 80–85 (1958)
Lodge, D., Headley, P.M., Duggan, A.W., Biscoe, T.J.: The effects of morphine, etorphine, and sinomenine on the chemical sensitivity and synaptic responses of Renshaw cells and other spinal neurones in the rat. Europ. J. Pharmacol. 26, 277–284 (1974)
Loewe, S.: Influence of chlorpromazine, reserpine, dibenzyline, and desoxycorticosterone upon morphine-induced feline mania. Arch. int. Pharmacodyn. 108, 453–456 (1956)
Loh, H.H., Shen, F.-H., Way, E.L.: Inhibition of morphine tolerance and physical dependence development and brain serotonin synthesis by cycloheximide. Biochem. Pharmacol. 18, 2711–2721 (1969)
Loh, H.H., Shen, F.-H., Way, E.L.: Effect of d-actinomycin on the acute toxicity and brain uptake of morphine. J. Pharmacol. exp. Ther. 177, 326–331 (1971)
Longo, V.G.: Electroencephalographic atlas for pharmacological research. Rabbit Brain Research, Vol. II. Amsterdam: Elsevier Publishing Co. 1962
Lorens, S.A., Mitchell, C.L.: Influence of morphine on lateral hypothalamic self-stimulation in the rat. Psychopharmacologia (Berl.) 32, 271–277 (1973)
Lorens, S.A., Yunger, L.M.: Morphine analgesia, two-way avoidance, and consummatory behavior following lesions in the midbrain raphe nuclei of the rat. Pharmacol. Biochem. Behav. 2, 215–221 (1974)
Lorenzetti, O.J., Sancilio, L.F.: Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch. int. Pharmacodyn. 183, 391–402 (1970)
Lowney, L.I., Schulz, K., Lowery, P.J., Goldstein, A.: Partial purification of an opiate receptor from mouse brain. Science 183, 749–753 (1974)
MacKay, E.M.: The relation of acquired morphine tolerance to the adrenal cortex. J. Pharmacol. exp. Ther. 43, 51–60 (1931)
MacKay, E.M., MacKay, L.L.: Resistance to morphine in experimental uremia. Proc. Soc. exp. Biol. (N.Y.) 24, 129 (1926)
McClane, T.K., Martin, W.R.: Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflex. Int. J. Neuropharmacol. 6, 89–98 (1967)
McKenzie, G.M., Sadof, M.: Effects of morphine and chlorpromazine on apomorphine-induced stereotyped behaviour. J. Pharm. Pharmacol. 26, 280–282 (1974)
McKenzie, J.S.: The influence of morphine and pethidine on somatic evoked responses in the hippocampal formation of the cat. Electroenceph. clin. Neurophysiol. 17, 428–431 (1964)
McKenzie, J.S., Beechey, N.R.: The effects of morphine and pethidine on somatic evoked responses in the midbrain of the cat, and the relevance to analgesia. Electroenceph. clin. Neurophysiol. 14, 501–519 (1962)
Maggiolo, C., Huidobro, F.: Administration of pellets of morphine to mice: Abstinence syndrome. Acta physiol. lat.-amer. 11, 70–78 (1961)
Maggiolo, C., Huidobro, F.: The influence of some drugs on the abstinence syndrome to morphine in mice. Arch. int. Pharmacodyn. 138, 157–168 (1962)
Maggiolo, C., Huidobro, F.: Studies on morphine. VIII. Action of drugs that mobilize aromatic alkyl-amines on the intensity of the abstinence syndrome to morphine in white mice. Acta physiol. lat.-amer. 15, 292–299 (1965)
Major, C.T., Pleuvry, B.J.: Effects of α-methyl-p-tyrosine, p-chlorophenylalanine, L-β-(3,4-dihydroxyphenyl)alanine, 5-hydroxytryptophan and diethyldithiocarbamate on the analgesic activity of morphine and methylamphetamine in the mouse. Brit. J. Pharmacol. 42, 512–521 (1971)
Marshall, I., Grahame-Smith, D.G.: Unchanged rate of brain serotonin synthesis during chronic morphine treatment and failure of parachlorophenylalanine to attenuate withdrawal syndrome in mice. Nature (Lond.) 228, 1206–1208 (1970)
Marshall, I., Grahame-Smith, D.G.: Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice. J. Pharmacol. exp. Ther. 173, 634–641 (1971)
Marshall, I., Smith, C.B.: Blockade of development of physical dependence on morphine by chronic inhibition of tyrosine hydroxylase. Pharmacologist 15, 243 (1973)
Marshall, I., Smith, C.B.: Acute and chronic morphine treatment and the hydroxylation of (1-14C)-L-tyrosine in the mouse brain. Brit. J. Pharmacol. 50, 428–430 (1974)
Martin, W.R.: Strong analgesics. In: Root, W.S., Hofman, F.G.: Physiological pharmacology, Vol. 1, pp.275–312. New York-London: Academic Press, 1963
Martin, W.R.: Assessment of the dependence producing potentiality of narcotic analgesics. In: Radouco-Thomas, C., Lasagna, L. (Eds.): International Encyclopedia of Pharmacology and Therapeutics, Sec. 6, Vol. 1, pp. 155–180. Glasgow: Pergamon Press 1966
Martin, W.R.: Opioid antagonists. Pharmacol. Rev. 19, 463–521 (1967)
Martin, W.R.: A homeostatic and redundancy theory of tolerance to and dependence on narcotic analgesics. In: Wikler, A. (Ed.): The addictive states, Ass. Res. nerv. ment. Dis., Vol.46, pp.206–225. Baltimore: Williams and Wilkins Co. 1968a
Martin, W.R.: The basis and possible utility of the use of opioid antagonists in the ambulatory treatment of the addict. In: Wikler, A. (Ed.): The addictive states, Ass. Res. nerv. ment. Dis., Vol.46, pp. 367–371. Baltimore: Williams and Wilkins 1968b
Martin, W.R.: Pharmacological redundancy as an adaptive mechanism in the central nervous system. Fed. Proc. 29, 13–18 (1970)
Martin, W.R.: Assessment of the abuse potentiality of amphetamines and LSD-like hallucinogens in man and its relationship to basic animal assessment programs. In: Goldberg, L., Hoffmeister, F.: Psychic dependence, Bayer Symposium IV, pp.146–155. Berlin-Heidelberg-New York: Springer 1973
Martin, W.R., Abdulian, D.H., Unna, K.R., Busch, H.: A study of the peripheral and central actions of dibromopyruvic acid. J. Pharmacol. exp. Ther. 124, 64–72 (1958)
Martin, W.R., Eades, C.G.: A comparative study of the effect of drugs on activating and vasomotor responses evoked by midbrain stimulation: Atropine, pentobarbital, chlorpromazine, and chlorpromazine sulfoxide. Psychopharmacologia (Berl.) 1, 303–335 (1960)
Martin, W.R., Eades, C.G.: Demonstration of tolerance and physical dependence in the dog following a short-term infusion of morphine. J. Pharmacol. exp. Ther. 133, 262–270 (1961)
Martin, W.R., Eades, C.G.: A comparison between acute and chronic physical dependence in the chronic spinal dog. J. Pharmacol. exp. Ther. 146, 385–394 (1964)
Martin, W.R., Eades, C.G.: Pharmacological studies of spinal cord adrenergic and cholinergic mechanisms and their relation to physical dependence on morphine. Psychopharmacologia (Berl.) 11, 195–223 (1967)
Martin, W.R., Eades, C.G.: Interactions between norepinephrine antagonists and potentiators (chlorpromazine, chlorpromazine sulfoxide, and imipramine) and sympathetic amines (amphetamine and methoxamine) on the flexor reflex of the chronic spinal dog. Int. J. Neuropharmacol. 7, 493–501 (1968)
Martin, W.R., Eades, C.G.: The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens. Psychopharmacologia (Berl.) 17, 242–257 (1970)
Martin, W.R., Eades, C.G.: Effects of phenethylamine (PEA) in the chronic spinal dog. Pharmacologist 16, 205 (1974)
Martin, W.R., Eades, C.G., Fraser, H.F., Wikler, A.: Use of hindlimb reflexes of the chronic spinal dog for comparing analgesics. J. Pharmacol. exp. Ther. 144, 8–11 (1964)
Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R.E., Gilbert, P.E.: The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. exp. Ther. 197, 517–532 (1976)
Martin, W.R., Eades, C.G., Thompson, W.O., Thompson, J.A., Flanary, H.G.: Morphine physical dependence in the dog. J. Pharmacol. exp. Ther. 189, 759–771 (1974)
Martin, W.R., Eisenman, A.J.: Interactions between nalorphine and morphine in the decerebrate cat. J. Pharmacol. exp. Ther. 138, 113–119 (1962)
Martin, W.R., Fraser, H.F.: A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J. Pharmacol. exp. Ther. 133, 388–399 (1961)
Martin, W.R., Fraser, H.F., Gorodetzky, C.W., Rosenberg, D.E.: Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20, 740, ARC II-C-3). J. Pharmacol. exp. Ther. 150, 426–436 (1965)
Martin, W.R., Gorodetzky, C.W.: Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). J. Pharmacol. exp. Ther. 150, 437–442 (1965)
Martin, W.R., Gorodetzky, C.W.: Cyclazocine, an adjunct in the treatment of narcotic addiction. Int. J. Addict. 2, 85–93 (1967)
Martin, W.R., Gorodetzky, C.W., McClane, T.K.: An experimental study in the treatment of narcotic addicts with cyclazocine. Clin. Pharmacol. Ther. 7, 455–465 (1966)
Martin, W.R., Gorodetzky, C.W., Thompson, W.O.: Receptor dualism: Some kinetic implications. In: Kosterlitz, H.W., Collier, H.O.J., Villarreal, J.E.: Agonist and antagonist actions of narcotic analgesic drugs (Proceedings of the symposium of the British Pharmacological Society, Aberdeen, July 1971), pp. 30–44. London: Macmillan Press 1973a
Martin, W.R., Jasinski, D.R.: Physiological parameters of morphine dependence in man-tolerance, early abstinence, protracted abstinence. J. psychiat. Res. 7, 9–17 (1969)
Martin, W.R., Jasinski, D.R., Haertzen, C.A., Kay, D.C., Jones, B.E., Mansky, P.A., Carpenter, R.W.: Methadone-A reevaluation. Arch. gen. Psychiat. 28, 286–295 (1973b)
Martin, W.R., Jasinski, D.R., Mansky, P.A.: Naltrexone, an antagonist for the treatment of heroin dependence. Arch. gen. Psychiat. 28, 784–791 (1973c)
Martin, W.R., Jasinski, D.R., Sapira, J.D., Flanary, H.G., Kelly, O.A, Thompson, A.K., Logan, C.R.: The respiratory effects of morphine during a cycle of dependence. J. Pharmacol. exp. Ther. 162, 182–189 (1968)
Martin, W.R., Kay, D.C.: Effects of opioid analgesics and antagonists on the EEG. In: Longo, G. (Ed.): International Handbook of EEG and Clinical Neurophysiology, Vol. 7, Part C, pp. 97–109. Amsterdam: Elsevier Publishing Co. 1977
Martin, W.R., Sloan, J.W.: The pathophysiology of morphine dependence and its treatment with opioid antagonists. Pharmakopsychiat. Neuropsychopharmakol. 1, 260–270 (1968)
Martin, W.R., Wikler, A., Eades, C.G., Pescor, F.T.: Tolerance to and physical dependence on morphine in rats. Psychopharmacologia (Berl.) 4, 247–260 (1963)
Maruyama, Y., Hayashi, G., Smits, S.E., Takemori, A.E.: Studies on the relationship between 5-hydroxytryptamine turnover in brain and tolerance and physical dependence in mice. J. Pharmacol. exp. Ther. 178, 20–29 (1971)
Maruyama, Y., Hayashi, G., Takemori, A.E.: Relation between 5-hydroxytryptamine (5-HT) and tolerance and physical dependence in mice. Pharmacologist 12, 231 (1970)
Maruyama, Y., Takemori, A.E.: The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice. J. Pharmacol. exp. Ther. 185, 602–608 (1973)
Master, A.M., Donoso, E.: Iproniazid in the anginal syndrome due to coronary disease. Ann. NY. Acad. Sci. 80, 1020–1038 (1959)
Matthews, J.D., Labrecque, G., Domino, E.F.: Effects of morphine, nalorphine and naloxone on neocortical release of acetylcholine in the rat. Psychopharmacologia (Berl.) 29, 113–120 (1973)
Mattila, M., Lavikainen, P.: The mouse tail reaction induced by morphine and the sedative action after reserpine and nalorphine. Ann. Med. exp. Fenn. 38, 115–120 (1960)
Mattila, M., Saarnivaara, L.: Potentiation by indomethacin and 5-hydroxytryptamine of opiate analgesia in rabbits. Scand. J. clin. Lab. Invest. 19, 62–63 (1967a)
Mattila, M.J., Saarnivaara, L.: Potentiation with indomethacin of the morphine analgesia in mice and rabbits. Ann. Med. exp. Fenn. 45, 360–363 (1967b)
Mattila, M.J, Saarnivaara, L.: Modification by antihistamine drugs of the morphine analgesia in rabbits. Ann. Med. exp. Fenn. 46, 72–77 (1968)
Mayer, D.J., Woffle, T.L., Akil, H., Carder, B., Liebeskind, J.C.: Analgesia from electrical stimulation in the brainstem of the rat. Science 174, 1351–1354 (1971)
Maynert, E.W.: Effects of morphine on acetylcholine and certain other neurotransmitters. Arch. Biol. Med. exp. (Santiago) 4, 36–41 (1967)
Maynert, E.W.: Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp.89–95. Baltimore: Williams and Wilkins 1968
Maynert, E.W., Klingman, G.I.: Tolerance to morphine. I. Effects on catecholamines in the brain and adrenal glands. J. Pharmacol. exp. Ther. 135, 285–295 (1962)
Maynert, E.W., Klingman, G.I., Kaji, H.K.: Tolerance to morphine. II. Lack of effects on brain 5-hydroxytryptamine and γ-aminobutyric acid. J. Pharmacol. exp. Ther. 135, 296–299 (1962)
Maynert, E.W., Levi, R.: Stress-induced release of brain norepinephrine and its inhibition by drugs. J. Pharmacol. exp. Ther. 143, 90–95 (1964)
Medaković, M., Banić, B.: The action of reserpine and α-methyl-m-tyrosine on the analgesic effect of morphine in rats and mice. J. Pharm. Pharmacol. 16, 198–206 (1964)
Menon, M.K., Dandiya, P.C., Bapna, J.S.: Modification of the effect of some central stimulants in mice pretreated with α-methyl-l-tyrosine. Psychopharmacologia (Berl.) 10, 437–444 (1967)
Merali, Z., Ghosh, P.K., Hrdina, P.D., Singhal, R.L., Ling, G.M.: Alterations in striatal acetylcholine, acetylcholine esterase, and dopamine after methadone replacement in morphine-dependent rats. Europ. J. Pharmacol. 26, 375–378 (1974)
Metys, J., Wagner, N., Metyšová, J., Herz, A.: Studies on the central antinociceptive action of cholinomimetic agents. Int. J. Neuropharmacol. 8, 413–425 (1969)
Michaud, G.M., Jacob, J.J.: Interactions between morphine and naloxone in the intact dog: A contribution to the problem of acute dependence. Presented at 35th Meeting, Committee on Problems of Drug Dependence, National Research Council, Chapel Hill, N.C. 1973
Miller, J.W., George, R., Elliott, H.W., Sung, C.Y., Way, E.L.: The influence of the adrenal medulla in morphine analgesia. J. Pharmacol. exp. Ther. 114, 43–50 (1955)
Milosević, M.P.: Effect of adrenaline on the analgesic response of mice to morphine and related drugs. Arch. int. Pharmacodyn. 104, 50–56 (1955)
Mizoguchi, K.: The sites of action of morphine and the antagonistic action of levallorphan on the central nervous system of the dog. Folia pharmacol. jap. 60, 326–346 (1964)
Monnier, M., Nosal, Gl., Radouco-Thomas, C.: Central mechanisms of pain analysed by the action of analgesics. In: Keele, C.A., Smith, R. (Eds.): The assessment of pain in man and animals, pp. 144–155. London: Universities Federation for Animal Welfare 1962
Moore, K.E., McCarthy, L.E, Borison, H.L.: Blood glucose and brain catecholamine levels in the cat following the injection of morphine into the cerebrospinal fluid. J. Pharmacol. exp. Ther. 148, 169–175 (1965)
Mosnaim, A.D., Inwang, E.E.: A spectrophotometric method for the quantification of 2-phenylethylamine in biological specimens. Analyt. Biochem. 54, 561–577 (1973)
Mudgill, L., Friedhoff, A.J., Tobey, J.: Effect of intraventricular administrations of epinephrine, norepinephrine, dopamine, acetylcholine, and physostigmine on morphine analgesia in mice. Arch. int. Pharmacodyn. 210, 85–91 (1974)
Mulé, S.J., Brill, H. (Eds.): Chemical and biological aspects of drug dependence. Cleveland, Ohio: Chemical Rubber Co. Press 1972
Mulé, S.J., Clements, T.H., Layson, R.C., Haertzen, C.A.: Analgesia in guinea pigs: A measure of tolerance development. Arch. int. Pharmacodyn. 173, 201–212 (1968)
Mullin, W.J., Phillis, J.W., Pinsky, C.: Morphine enhancement of acetylcholine release from the brain in unanaesthetized cats. Europ. J. Pharmacol. 22, 117–119 (1973)
Mũnoz, C.: Role of catecholamines in morphine analgesia. Acta physiol. lat.-amer. 18, 277 (1968)
Mũnoz, C., Paeile, C.: Changes in morphine analgesia induced by drugs which modify catecholamine content of the brain. Arch. Biol. Med. exp. (Santiago) 4, 63–68 (1967)
Murphy, D.L.: Mental effects of L-DOPA. Ann. Rev. Med. 24, 209–216 (1973)
Nakamura, J., Mitchell, C.L.: The effects of morphine, pentobarbital and saline on bioelectrical potentials recorded in limbic structures of the cat evoked by radial nerve and direct brain stimulation. Arch. int. Pharmacodyn. 200, 70–87 (1972)
Nakamura, J., Winters, W.D.: Attenuation of the morphine EEG continuum following a repeat dose within 16 days: Delayed tolerance in the rat. Neuropharmacology 12, 607–617 (1973)
Nakamura, K., Kuntzman, R., Maggio, A.C., Augulis, V.: Influence of 6-hydroxydopamine on the effect of morphine on the tail-flick latency. Psychopharmacologia (Berl.) 31, 177–189 (1973a)
Nakamura, K., Kuntzman, R., Maggio, A., Conney, A.H.: Effect of 6-hydroxy-dopamine on catecholamine concentrations and behaviour in the morphine-tolerant rat. J. Pharm. Pharmacol. 24, 484–487 (1972)
Nakamura, K., Kuntzman, R., Maggio, A., Conney, A.H.: Restoration of morphine analgesia in morphine-tolerant rats after the intraventricular administration of 6-hydroxydopamine. J. Pharm. Pharmacol. 25, 584–587 (1973b)
Nash, P., Colasanti, B., Khazan, N.: Long-term effects of morphine on the electroencephalogram and behavior of the rat. Psychopharmacologia (Berl.) 29, 271–276 (1973)
Navarro, G., Elliott, H.W.: The effects of morphine, morphinone, and thebaine on the EEG and behavior of rabbits and cats. Neuropharmacology 10, 367–377 (1971)
Neal, M.J.: Failure of morphine dependence in rats to influence brain noradrenaline turnover. J. Pharm. Pharmacol. 20, 950–953 (1968)
Neuman, R.S., Calvillo, O., Henry, J.L.: Blockade by morphine of nociceptive neurones in the dorsal horn of the cat. Pharmacologist 16, 203 (1974)
Nicák, A.: The influence of serotonine and amphetamine on analgesic effect of morphine after reserpine premedication in rats and mice. Med. Pharmacol. exp. 13, 43–48 (1965)
Nutt, J.G., Jasinski, D.R.: Comparison of intravenously administered methadone, morphine, heroin, and placebo. Fed. Proc. 32, 694 (1973)
Ogiu, K., Takagi, H., Yamamoto, S.: Studies on the site of antagonistic action of nalorphine on morphine. Folia pharmacol. jap. 54, 1–6 (1958)
Olds, J.: Selfs-stimulation of the brain. Its use to study local effects of hunger, sex, and drugs. Science 127, 315–324 (1958)
Olds, J., Travis, R.P.: Effects of chlorpromazine, meprobamate, pentobarbital, and morphine on self-stimulation. J. Pharmacol. exp. Ther. 128, 397–404 (1960)
Oliverio, A., Castellano, C.: Genotype-dependet sensitivity and tolerance to morphine and heroin: Dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia (Berl.) 39, 13–22 (1974)
Olson, R.W.: MMPI sex differences in narcotic addicts. J. gen. Psychol. 71, 257–266 (1964)
Opitz, K., Reimann, L.: Suppression of the drug-induced morphine withdrawal syndrome by cyproheptadine. Psychopharmacologia (Berl.) 28, 165–170 (1973)
Outschoorn, A.S.: The hormones of the adrenal medulla and their release. Brit. J. Pharmacol. 7, 605–615 (1952)
Paalzow, L.: Analgesia produced by clonidine in mice and rats. J. Pharm. Pharmacol. 26, 361–363 (1974)
Parker, R.B.: Mouse locomotor activity: Effect of morphine, narcotic antagonists, and the interaction of morphine and narcotic antagonists. Psychopharmacologia (Berl.) 38, 15–23 (1974)
Pasternak, G.W., Goodman, R., Snyder, S.H.: An endogenous morphine-like factor in mammalian brain. Life Sci. 16, 1765–1769 (1975)
Paton, W.D.M.: The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea pig ileum. Brit. J. Pharmacol. 12, 119–127 (1957)
Pelikan, E.W.: The mechanism of ganglionic blockade produced by nicotone. Ann. N.Y. Acad. Sci. 90, 52–69 (1960)
Perez-Cruet, J., DiChiara, G., Gessa, G.L.: Accelerated synthesis of dopamine in the rat brain after methadone. Experientia (Basel) 28, 926 (1972)
Pert, A., Yaksh, T.: Sites of morphine induced analgesia in the primate brain: relation to pain pathways. Brain Res. 80, 135–140 (1974)
Pert, C.B., Snyder, S.H.: Opiate receptor: Demonstration in nervous tissue. Science 179, 1011–1014 (1973a)
Pert, C.B., Snyder, S.H.: Properties of opiate-receptor binding in rat brain. Proc. nat. Acad. Sci. (Wash.) 70, 2243–2247 (1973b)
Phillis, J.W., Mullin, W.J., Pinsky, C.: Morphine enhancement of acetycholine release into the lateral ventricle and from the cerebral cortex of unanesthetized cats. Comp. gen. Pharmacol. 4, 189–200 (1973)
Pinsky, C., Frederickson, R.C.A., Vazquez, A.J.: Morphine withdrawal snydrome responses to cholinergic antagonists and to a partial cholinergic agonist. Nature (Lond.) 242, 59–60 (1973)
Plant, O.H., Pierce, I.H.: Studies of chronic morphine poisoning in dogs. I. General symptoms and behavior during addiction and withdrawal. J. Pharmacol. exp. Ther. 33, 329–357 (1928)
Pleuvry, B.J.: Cross tolerance between methylamphetamine and morphine in the mouse. J. Pharm. Pharmacol. 23, 969–970 (1971)
Pleuvry, B.J., Tobias, M.A.: Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse. Brit. J. Pharmacol. 43, 706–714 (1971)
Pollock, D., Muir, T.C., MacDonald, A., Henderson, G.: Morphine-induced changes in the sensitivity of the isolated colon and vas deferens of the rat. Europ. J. Pharmacol. 20, 321–328 (1972)
Proudfit, H.K., Anderson, E.G.: Blockade of morphine analgesia by destruction of a bulbospinal serotonergic pathway. Pharmacologist 16, 203 (1974)
Pruitt, D.B., Grubb, M.N., Jaquette, D.L., Burks, T.F.: Intestinal effects of 5-hydroxytryptamine and morphine in guinea pigs, dogs, cats, and monkeys. Europ. J. Pharmacol. 26, 298–305 (1974)
Puharich, V., Goetzl, F.R.: The influence of adrenalectomy upon analgesic effectiveness of morphine in rats. Permanente Fdn. med. Bull. 5, 19–22 (1947)
Puri, S.K., Lal, H.: Effect of apomorphine, benztropine or morphine on striatal dopamine turnover: Evidence for latent supersensitivity of dopaminergic receptors in morphine dependent rats. Pharmacologist 15, 247 (1973a)
Puri, S.K., Lal, H.: Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression. Psychopharmacologia (Berl.) 32, 113–120 (1973b)
Puri, S.K., Lal, H.: Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol. Naunyn-Schmiedebergs Arch. exp. Path. Pharmakol. 282, 155–170 (1974a)
Puri, S.K., Lal, H.: Reduced threshold to pain induced aggression specifically related to morphine dependence. Psychopharmacologia (Berl.) 35, 237–241 (1974b)
Puri, S.K., Reddy, C., Lal, H.: Blockade of central dopaminergic receptors by morphine: Effect of haloperidol, apomorphine or benztropine. Res. Comm. chem. Pathol. Pharmacol. 5, 389–401 (1973)
Quinn, G.P., Brodie, B.B., Shore, P.A.: Drug-induced release of norepinephrine in cat brain. J. Pharmacol exp. Ther. 122, 63A (1958)
Radouco-Thomas, C., Nosal, Gl., Radouco-Thomas, S. (in collaboration with Chaumontet, J.M. and Capt, M.): On the experimental pain threshold in animals. In: Keele, C.A., Smith, R. (Eds.): The assessment of pain in man and animals, pp.271–289. London: Universities Federation for Animal Welfare 1962
Radouco-Thomas, S., Singh, P., Garcin, F., Radouco-Thomas, C.: Relationship between experimental analgesia and brain monoamines: Catecholamines and 5-hydroxytryptamine. Effects of precursors (DOPA, 5HTP) and monoamines modifying drugs. Arch. Biol. med. exp. (Santiago) 4, 42–62 (1967)
Rech, R.H., Tilson, H.A.: Effects of p-chlorophenylalanine (p-CPA) on morphine analgesia and development of tolerance and dependence in two strains of rats. Pharmacologist 15, 202 (1973)
Reis, D.J., Rifkin, M., Corvelli, A.: Effects of morphine on cat brain norepinephrine in regions with daily monoamine rhythms. Europ. J. Pharmacol. 9, 149–152 (1969)
Repkin, A.H., Proudfit, H.K., Anderson, E.G.: Primary afferent depolarization as a mechanism of morphine analgesia. Pharmacologist 16, 203 (1974)
Rethy, C.R., Smith, C.B., Villarreal, J.E.: Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse. J. Pharmacol. exp. Ther. 176, 472–479 (1971)
Reynolds, A.K., Randall, L.O.: Morphine and allied drugs. Toronto: University of Toronto Press 1957
Riblet, L.A., Mitchell, C.L.: The effect of cervical spinal section on the ability of morphine to elevate the jaw jerk threshold to electrical stimulation of the tooth pulp in cats. J. Pharmacol. exp. Ther. 180, 610–615 (1972)
Richardson, J.A., Woods, E.F., Richardson, A.K.: Elevations in plasma catecholamines following morphine. J. Pharmacol. exp. Ther. 122, 64A (1958)
Richter, J.A., Goldstein, A.: Effects of morphine and levorphanol on brain acetylcholine content in mice. J. Pharmacol. exp. Ther. 175, 685–691 (1970)
Risner, M.E.: The possible lack of noradrenergic mechanisms in d-amphetamine (A) self-administration. Fed. Proc. 34, 768 (1975)
Risner, M.E., Khavari, K.A.: Morphine dependence in rats produced after five days of ingestion. Psychopharmacologia (Berl.) 28, 51–62 (1973)
Ritchie, J.M., Armett, C.J.: On the role of acetylcholine in conduction in mammalian nonmyelinated nerve fibers. J. Pharmacol. exp. Ther. 139, 201–207 (1963)
Rosenman, S.J., Smith, C.B.: 14C-Catecholamine synthesis in mouse brain during morphine withdrawal. Nature (Lond.) 240, 153–156 (1972)
Ross, J.W., Ashford, A.: The effect of reserpine and α-methyldopa on the analgesic action of morphine in the mouse. J. Pharm. Pharmacol. 19, 709–713 (1967)
Rudzik, A.D., Mennear, J.H.: Antagonism of analgesics by amine-depleting agents. J. Pharm. Pharmacol. 17, 326–327 (1965)
Saarnivaara, L.: Effect of 5-hydroxytryptamine on morphine analgesia in rabbits. Ann. Med. exp. Fenn. 47, 113–123 (1969a)
Saarnivaara, L.: Analgesic activity of some sympathetic drugs and their effect on morphine analgesia in rabbits. Ann. Med. exp. Fenn. 47, 180–190 (1969b)
Saavedra, J.M.: Enzymatic isotopic assay for and presence of β-phenylethylamine in brain. J. Neurochem. 22, 211–216 (1974)
Samanin, R., Bernasconi, S.: Effects of intraventricularly injected 6-OH dopamine or midbrain raphe lesion on morphine analgesia in rats. Psychopharmacologia (Berl.) 25, 175–182 (1972)
Samanin, R., Ghezzi, D., Mauron, C., Valzelli, L.: Effect of midbrain raphe lesion on the antinociceptive action of morphine and other analgesics in rats. Psychopharmacologia (Berl.) 33, 365–368 (1973)
Samanin, R., Gumulka, W., Valzelli, L.: Reduced effect of morphine in midbrain raphé lesioned rats. Europ. J. Pharmacol. 10, 339–343 (1970)
Samanin, R., Valzelli, L.: Increase of morphine-induced analgesia by stimulation of the nucleus raphé dorsalis. Europ. J. Pharmacol. 16, 298–302 (1971)
Sasame, H.A., Perez-Cruet, J., DiChiara, G., Tagliamonte, A., Tagliamonte, P., Gessa, G.L.: Evidence that methadone blocks dopamine receptors in the brain. J. Neurochem. 19, 1953–1957 (1972)
Satake, Y.: Secretion of adrenaline and sympathins. Tôhoku,J. exp. Med. 60, Suppl. II, 1954
Sato, H., Ohmi, F.: Action of morphine on the epinephrine output, blood sugar content and blood pressure in dogs. Tôhoku J. exp. Med. 21, 411–432 (1933)
Satoh, M., Takagi, H.: Enhancement by morphine of the central descending inhibitory influence on spinal sensory transmission. Europ. J. Pharmacol. 14, 60–65 (1971a)
Satoh, M., Takagi, H.: Effect of morphine on the pre-and postsynaptic inhibitions in the spinal cord. Europ. J. Pharmacol. 14, 150–154 (1971b)
Saxena, P.N., Gupta, G.P.: Potentiating effect of prostigmine on morphine-induced analgesia. Indian J. med. Res. 45, 319–325 (1957)
Sawyer, C.H., Critchlow, B.V., Barraclough, C.A.: Mechanism of blockade of pituitary activation in the rat by morphine, atropine, and barbiturates. Endocrinology 57, 345–354 (1955)
Schallek, W., Kühn, A.: Effects of drugs on spontaneous and activated EEG of cat. Arch. int. Pharmacodyn. 120, 319–333 (1959)
Schaumann, W.: The paralysing action of morphine on the guinea pig ileum. Brit. J. Pharmacol. 10, 456–461 (1955)
Schaumann, W.: Inhibition by morphine of the release of acetylcholine from the intestine of the guinea pig. Brit. J. Pharmacol. 12, 115–117 (1957)
Schaumann, W.: Beeinflussung der analgetischen Wirkung des Morphins durch Reserpin. Naunyn Schmiedebergs Arch. exp. Path. Pharmak. 235, 1–9 (1958)
Schmitt, H., LeDouarec, J.-C, Petillot, N.: Antinociceptive effects of some α-sympathomimetic agents. Neuropharmacology 13, 289–294 (1974)
Schneider, J.A.: Reserpine antagonism of morphine analgesia in mice. Proc. Soc. exp. Biol. (N.Y.) 87, 614–615 (1954)
Schuberth, J., Sundwall, A.: Effects of some drugs on the uptake of acetylcholine in cortex slices of mouse brain. J. Neurochem. 14, 807–812 (1967)
Schulz, R., Cartwright, C.: Effect of morphine on serotonin release from myenteric plexus of the guinea pig. J. Pharmacol. exp. Ther. 190, 420–430 (1974)
Schulz, R., Cartwright, C., Goldstein, A.: Reversibility of morphine tolerance and dependence in guinea pig brain and myenteric plexus. Nature (Lond.) 251, 329–331 (1974)
Schulz, R., Goldstein, A.: Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea pig. Nature (Lond.) 244, 168–170 (1973)
Schwartz, A.S., Eidelberg, E.: Role of biogenic amines in morphine dependence. Life Sci. 9, 613–624 (1970)
Schweizer, W.: Isopropythydrazides in angina pectoris. Ann. N. Y. Acad. Sci. 80, 1016–1019 (1959)
Seevers, M.H.: Opiate addiction in the monkey. I. Methods of study. J. Pharmacol. exp. Ther. 56, 147–156 (1936)
Seevers, M.H.: Possible mechanisms of physical dependence to narcotics. In: Sevag, M.G., Reid, R.D., Reynolds, O.E. (Eds.): Origins of resistance to toxic agents, pp.244–263. New York: Academic Press 1955
Seevers, M.H., Deneau, G.A.: A critique of the “dual action” hypothesis of morphine physical dependence. Arch. int. Pharmacodyn. 140, 514–520 (1962)
Seevers, M.H., Deneau, G.A.: Physiological aspects of tolerance and physical dependence. In: Root, W.S., Hofmann, F.G. (Eds.): Physiological pharmacology. Vol.1, pp.565–640. New York: Academic Press 1963
Segal, M., Deneau, G.A.: Brain levels of epinephrine, norepinephrine, dopamine and 5-HT during administration and withdrawal of morphine in monkeys. Fed. Proc. 21, 327 (1962)
Segal, M., Deneau, G.A., Seevers, M.H.: Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys. Neuropharmacology 11, 211–222 (1972)
Sethy, V.H., Prahdan, R.J., Mandrekar, S.S., Sheth, U.K.: Role of brain amines in the analgesic action of meperidine hydrochloride. Psychopharmacologia (Berl.) 17, 320–326 (1970)
Sewell, R.D.E., Spencer, P.S.J.: Modification of the antinociceptive activity of narcotic agonists and antagonists by intraventricular injection of biogenic amines in mice. Brit. J. Pharmacol. 51, 140–141 P (1974)
Sharkawi, M., Goldstein, A.: Antagonism by physostigmine of the “running fit” caused by levorphanol, a morphine congener, in mice. Brit. J. Pharmacol. 37, 123–128 (1969)
Sharkawi, M., Schulman, M.R.: Inhibition by morphine of the release of 14C acetylcholine from rat brain cortex slices. J. Pharm. Pharmacol. 21, 546–547 (1969)
Sharman, D.F.: Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Brit. J. Pharmacol. 28, 153–163 (1966)
Shein, H.M., Larin, F., Wurtman, R.J.: Lack of a direct effect of morphine on the synthesis of pineal 14C-indoles in organ culture. Life Sci. 9, 29–33 (1970)
Sheldon, M.I., Smith, C.B.: Effects of morphine and of forced running upon 14C-catecholamine synthesis in various tissues of the mouse. Pharmacologist 13, 313 (1971)
Shen, F., Loh, H.H., Way, E.L.: Reserpine antagonism of morphine analgesia in tolerant mice. Fed. Proc. 28, 793 (1969)
Shen, F.H., Loh, H.H., Way, E.L.: Brain serotonin turnover in morphine tolerant and dependent mice. J. Pharmacol. exp. Ther. 175, 427–434 (1970)
Sherbel, A.L., Harrison, J.W.: The effects of iproniazid and other amine oxidase inhibitors in rheumatoid arthritis. Ann. NY. Acad. Sci. 80, 820–834 (1959)
Sherman, A.D., Mitchell, C.L.: Effect of morphine on regional levels of gamma-hydroxybutyrate in mouse brain. Neuropharmacology 13, 239–243 (1974)
Shiomi, H., Takagi, H.: Morphine analgesia and the bulbospinal noradrenergic system: Increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics. Brit. J. Pharmacol. 52, 519–526 (1974)
Shoham, S., Weinstock, M.: The role of supersensitivity to acetylcholine in the production of tolerance to morphine in stimulated guinea pig ileum. Brit. J. Pharmacol. 52, 597–603 (1974)
Shuster, L.: Repression and de-repression of enzyme synthesis as a possible explanation of some aspects of drug action. Nature (Lond.) 189, 314–315 (1961)
Shuster, L., Hannam, R.V., Boyle, W.E., Jr.: A simple method for producing tolerance to dihydromorphinone in mice. J. Pharmacol. exp. Ther. 140, 149–154 (1963)
Sibuta, H., Endo, K., Nagakura, G.: The increase of the epinephrine output under morphine depends upon the integrity of the splanchnic nerves. Tôhoku J. exp. Med. 50, 1–6 (1949)
Sigg, E.B., Caprio, G., Schneider, J.A.: Synergism of amines and antagonism of reserpine to morphine analgesia. Proc. Soc. exp. Biol. (NY.) 97, 97–100 (1958)
Silver, S.: Über die Schmerzüberempfindlichkeit durch Schlafmittel und ihre Beeinflussung. Ein Beitrag zum Mechanismus der Morphiumwirkung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 158, 219–232 (1930)
Silvestrini, B., Longo, V.G.: Selective activity of morphine on the “EEG arousal reaction” to painful stimuli. Experientia (Basel) 12, 436–437 (1956)
Simon, E.J.: Sites of action of narcotic analgesic drugs: Single cells. In: Clouet, D.H. (Ed.): Narcotic drugs; biochemical pharmacology, pp.310–341. New York-London: Plenum Press 1971
Simon, E.J., Hiller, J.M., Edelman, I.: Stereospecific binding of the potent narcotic analgesic (3H) etorphine to rat-brain homogenate. Proc. nat. Acad. Sci. (Wash.) 70, 1947–1949 (1973)
Simon, E.J., Rosenberg, P.: Effects of narcotics on the giant axon of the squid. J. Neurochem. 17, 881–887 (1970)
Sinclair, J.G.: Morphine and meperidine on bulbospinal inhibition of the monosynaptic reflex. Europ. J. Pharmacol. 21, 111–114 (1973)
Sinitsin, L.N.: Effect of morphine and other analgesics on brain evoked potentials. Int. J. Neuropharmacol. 3, 321–326 (1964)
Slaughter, D., Gross, E.G.: Some new aspects of morphine action. Effect on intestine and blood pressure; toxicity studies. J. Pharmacol. exp. Ther. 68, 96–103 (1940)
Slaughter, D., Munsell, D.W.: Some new aspects of morphine action. Effects on pain. J. Pharmacol. exp. Ther. 68, 104–112 (1940)
Sloan, J.W., Brooks, J.W., Eisenman, A.J., Martin, W.R.: Comparison of the effects of single doses of morphine and thebaine on body temperature, activity and brain and heart levels of catecholamines and serotonin. Psychopharmacologia (Berl.) 3, 291–301 (1962)
Sloan, J.W., Brooks, J.W., Eisenman, A.J., Martin, W.R.: The effect of addiction to and abstinence from morphine on rat tissue catecholamine and serotonin levels. Psychopharmacologia (Berl.) 4, 261–270 (1963)
Sloan, J.W., Eisenman, A.J.: Long-persisting changes in catecholamine metabolism following addiction to and withdrawal from morphine. In: Wikler, A. (Ed.): The addictive states. Ass. Res. nerv. ment. Dis., Vol.46, pp.96–105. Baltimore: Williams & Wilkins 1968
Smith, A.A., Karmin, M., Gavitt, J.: Blocking effect of puromycin, ethanol, and chloroform on the development of tolerance to an opiate. Biochem. Pharmacol. 15, 1877–1879 (1966)
Smith, A.A., Karmin, M., Gavitt, J.: Tolerance to the lenticular effects of opiates. J. Pharmacol. exp. Ther. 156, 85–91 (1967)
Smith, C.B., Sheldon, M.I., Bednarczyk J.H., Villarreal, J.E.: Morphine-induced increases in the incorporation of 14C-tyrosine into 14C-dopamine and 14C-norepinephrine in the mouse brain: Antagonism by naloxone and tolerance. J. Pharmacol. exp. Ther. 180, 547–557 (1972)
Smith, C.B., Villarreal, J.E., Bednarczyk, J.H., Sheldon, M.I.: Tolerance to morphine-induced increases in 14C catecholamine synthesis in mouse brain. Science 170, 1106–1107 (1970)
Smith, G.M., Beecher, H.K.: Measurement of “mental clouding” and other subjective effects of morphine. J. Pharmacol. exp. Ther. 126, 50–62 (1959)
Smith, G.M., Beecher, H.K.: Subjective effects of heroin and morphine in normal subjects. J. Pharmacol. exp. Ther. 136, 47–52 (1962)
Smith, G.M., Semke, C.W., Beecher, H.K.: Objective evidence of mental effects of heroin, morphine and placebo in normal subjects. J. Pharmacol. exp. Ther. 136, 53–58 (1962)
Smits, S.E., Takemori, A.E.: Lack of transfer of morphine tolerance by administration of rat cerebral homogenates. Proc. Soc. exp. Biol. (N.Y.) 127, 1167–1171 (1968)
Soteropoulos, G.G., Standaert, F.G.: Neuromuscular effects of morphine and naloxone. J. Pharmacol. exp. Ther. 184, 136–142 (1973)
Soulairac, A., Cahn, J., Charpentier, J.: Pain (Proceedings of the International Symposium on Pain, Paris, April 11–13, 1967). New York: Academic Press 1968
Soulairac, A., Gottesmann, Cl., Charpentier, J.: Effects of pain and of several central analgesics on cortex, hippocampus and reticular formation of brain stem. Int. J. Neuropharmacol. 6, 71–81 (1967)
Sparkes, G.G., Spencer, P.S.J.: Modification of morphine analgesia in the rat by biogenic amines administered intraventricularly. Brit. J. Pharmacol. 35, 362P–363P (1969)
Spector, S.: Quantitative determination of morphine in serum by radioimmunoassay. J. Pharmacol. exp. Ther. 178, 253–258 (1971)
Spector, S., Parker, C.W.: Morphine: Radioimmunoassay. Science 168, 1347–1348 (1970)
Spoerlein, M.T., Scrafini, J.: Effects of time and 8-azaquanine on the development of morphine tolerance. Life Sci. 6, 1549–1564 (1967)
Steinert, H.R., Holtzman, S.G., Jewett, R.E.: Some agonistic actions of the morphine antagonist levallorphan on behavior and brain monoamines in the rat. Psychopharmacologia (Berl.) 31, 35–48 (1973)
Stern, P.: Substance P as a sensory transmitter and its other central effects. Ann. NY. Acad. Sci. 104, 403–415 (1963)
Stern, P., Hadžović, J.: Pharmacological analysis of central actions of synthetic Substance P. Arch. int. Pharmacodyn. 202, 259–262 (1973)
Stern, P., Hukovíc, S.: Beziehungen zwischen zentraler und peripherer Wirkung der Substanz P. Med exp. (Berl.) 2, 1–7 (1960)
Stewart, G.N., Rogoff, J.M.: The influence of certain factors, especially emotional disturbances, on the epinephrin content of the adrenals. J. exp. Med. 24, 709–738 (1916)
Stewart, G.N., Rogoff, J.M.: The action of drugs on the output of epinephrin from the adrenals. VIII. Morphine. J. Pharmacol. exp. Ther. 19, 59–85 (1922)
Stille, G.: Zur Pharmakologie katatonigener Stoffe. 4. Mitteilung: Die Wirkung von Morphin. Arzneimittel-Forsch. (Drug Res.) 21, 650–654 (1971)
Sturtevant, F.M., Drill, V.A.: Tranquillizing drugs and morphine-mania in cats. Nature (Lond.) 179, 1253 (1957)
Sugrue, M.F.: The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain. Brit. J. Pharmacol. 52, 159–165 (1974)
Sung, C.Y., Way, E.L., Scott, K.G.: Studies on the relationship of metabolic fate and hormonal effects of D,L-methadone to the development of drug tolerance. J. Pharmacol. exp. Ther. 107, 12–23 (1953)
Sweet, W.H.: Pain. In: Handbook of Physiology, Section 1: Neurophysiology, Vol. 1, pp.459–506. Washington, D.C.: American Physiological Society 1959
Tachikawa, Y.: Effect of morphine injections on blood-sugar and adrenalin in dogs. J. Orient. Med. 17, 521–528 (1932)
Takagi, H., Nakama, M.: Effect of morphine and nalorphine on the content of dopamine in mouse brain. Jap. J. Pharmacol. 16, 483–484 (1966)
Takagi, H., Nakama, M.: Studies on the mechanism of action of tetrabenazine as a morphine antagonist. II. A participation of catecholamine in the antagonism. Jap. J. Pharmacol. 18, 54–58 (1968)
Takagi, H., Matsumura, M., Yanai, A., Ogiu, K.: The effect of analgesics on the spinal reflex activity of the cat. Jap. J. Pharmacol. 4, 176–187 (1955)
Takagi, H., Takashima, T., Kimura, K.: Antagonism of the analgetic effect of morphine in mice by tetrabenazine and reserpine. Arch. int. Pharmacodyn. 149, 484–492 (1964)
Takagi, K., Takayanagi, I., Irikura, T., Nishino, K., Ichinoseki, N., Shishido, K.: Responses of the isolated ileum of the morphine-tolerant guinea pig. Arch. int. Pharmacodyn. 158, 39–44 (1965)
Takemori, A.E., Oka, T., Nishiyama, N.: Alteration of analgesic receptor-antagonist interaction induced by morphine. J. Pharmacol. exp. Ther. 186, 261–265 (1973)
Takemori, A.E., Tulunay, F.C.: Further studies on the receptor alteration induced by morphine. Pharmacologist 15, 242 (1973)
Tamarkin, N.R., Goodwin, F.K., Axelrod, J.: Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci. 9, 1397–1408 (1970)
Tanabe, T., Cafruny, E.J.: Adrenal hypertrophy in rats treated chronically with morphine. J. Pharmacol. exp. Ther. 122, 148–153 (1958)
Tatum, A.L., Seevers, M.H., Collins, K.H.: Morphine addiction and its physiological interpretation based on experimental evidences. J. Pharmacol. exp. Ther. 36, 447–475 (1929)
Teitelbaum, H., Catravas, G.N, McFarland, W.L.: Reversal of morphine tolerance after medial thalamic lesions in the rat. Science 185, 449–451 (1974)
Tenen, S.S.: The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat. Psychopharmacologia (Berl.) 10, 204–219 (1967)
Tenen, S.S.: Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychopharmacologia (Berl.) 12, 278–285 (1968)
Terenius, L.: Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta pharmacol. toxicol. 32, 317–320 (1973)
Terenius, L.: Effect of peptides and amino acids on dihydromorphine binding to the opiate receptor. J. Pharm. Pharmacol. 27, 450–452 (1975)
Terenius, L., Gispen, W.H., De Wied, D.: ACTH-like peptides and opiate receptors in the rat brain: Structure-activity studies. Europ. J. Pharmacol. 33, 395–399 (1975)
Terenius, L., Wahlström, A.: Inhibitor(s) of narcotic receptor binding in brain extracts and cerebrospinal fluid. Acta pharmacol. 35, (Suppl.): 55, 1974
Terenius, L., Wahlström, A.: Search for an endogenous ligand for the opiate receptor. Acta physiol. scand. 94, 74–81 (1975a)
Terenius, L., Wahlström, A.: Morphine-like ligand for opiate receptors in human CSF. Life Sci. 16, 1759–1764 (1975b)
Teschemacher, H., Opheim, K.E., Cox, B.M., Goldstein, A.: A peptide-like substance from pituitary that acts like morphine. 1. Isolation. Life Sci. 16, 1771–1776 (1975)
Teschemacher, Hj., Schubert, P., Herz, A.: Autoradiographic studies concerning the supraspinal site of the antinociceptive action of morphine when inhibiting the hindleg flexor reflex in rabbits. Neuropharmacology 12, 123–131 (1973)
Tilson, H.A., Rech, R.H., Stolman, S.: Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia (Berl.) 28, 287–300 (1973)
Tirri, R.: Transfer of induced tolerance to morphine and promazine by brain homogenate. Experientia (Basel) 23, 278 (1967)
Torda, C., Wolff, H.G.: Effect of convulsant and anticonvulsant agents on acetylcholine metabolism (activity of choline acetylase, cholinesterase) and on sensitivity to acetylcholine of effector organs. Amer. J. Physiol. 151, 345–354 (1947)
Trafton, C.L., Marques, P.R.: Effects of septal area and cingulate cortex lesions on opiate addiction behavior in rats. J. comp. physiol. Psychol. 75, 277–285 (1971)
Trendelenberg, P.: Physiologische und pharmakologische Versuche über die Dünndarmperistaltik. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 81, 55–129 (1917)
Trendelenburg, U.: The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat. Brit. J. Pharmacol. 12, 79–85 (1957)
Tripod, J., Gross, F.: Unterschiedliche Beeinflussung der analgetischen und der erregenden Wirkung von Morphin durch zentral dämpfende Pharmaka. Helv. physiol. pharmacol. Acta. 15, 105–116 (1957)
Tseng, L.F., Loh, H.H., Ho, I.K., Way, E.L.: The role of brain catecholamines in naloxone induced withdrawal in morphine dependent rats. Proc. West. Pharmacol. Soc. 17, 178–183 (1974)
Tsou, K., Jang, C.S.: Studies on the site of analgesic action of morphine by intracerebral microinjections. Scientia Sinica 8, 1099–1109 (1964)
Tulunay, F.C., Takemori, A.E.: The increased efficacy of narcotic antagonists induced by various narcotic analgesics. J. Pharmacol. exp. Ther. 190, 395–400 (1974a)
Tulunay, F.C., Takemori, A.E.: Further studies on the alteration of analgesic receptor-antagonist interaction induced by morphine. J. Pharmacol. exp. Ther. 190, 401–407 (1974b)
Türker, K., Akcasu, A.: The effect of morphine on 5-HT content of cat’s brain. New Istanbul Contr. clin. Sci. 5, 89–97 (1962)
Tuttle, W.W., Elliott, H.W.: Electrographic and behavioral study of convulsants in the cat. Anesthesiology 30, 48–64 (1969)
Ungar, G., Cohen, M.: Induction of morphine tolerance by material extracted from brain of tolerant animals. Int. J. Neuropharmacol. 5, 183–192 (1966)
Ungar, G., Galvan, L.: Conditions of transfer of morphine tolerance by brain extracts. Proc. Soc. exp. Biol. (N.Y.) 130, 287–291 (1969)
Val’dman, A.V.: The effect of analgesics on the descending reticular inhibitory system of the brainstem. New Data on the Pharmacology of the Reticular Formation of the Cerebrum, Leningrad Medical Institute, Leningrad, USSR 1958
Vaupel, D.B., Martin, W.R.: Interaction of oxotremorine with atropine, chlorpromazine, cyproheptadine, imipramine and phenoxybenzamine on the flexor reflex of the chronic spinal dog. Psychopharmacologia (Berl.) 30, 13–26 (1973)
Vedernikov, Yu.P.: Interaction of amphetamine, apomorphine, disulfiram with morphine and the role played by catecholamines in morphine analgesic action. Arch. int. Pharmacodyn. 182, 59–64 (1969)
Vedernikov, Yu.P.: The influence of single and chronic morphine administration on some central effects of amphetamine and apomorphine. Psychopharmacologia (Berl.) 17, 283–288 (1970)
Vedernikov, Yu.P., Afrikanov, I.I.: On the role of a central adrenergic mechanism in morphine analgesic action. J. Pharm. Pharmacol. 21, 845–847 (1969)
Verdeaux, G., Marty, R.: Action sur l’électroencéphalogramme de substances pharmacodynamiques d’intérêt clinique. Revue neurol. 91, 405–427 (1954)
Verri, R.A., Graeff, F.G., Corrado, A.P.: Effect of reserpine and alpha-methyl-tyrosine on morphine analgesia. Int. J. Neuropharmacol. 7, 283–292 (1968)
Vigouret, J., Teschemacher, Hj., Albus, K., Herz, A.: Differentiation between spinal and supra-spinal sites of action of morphine when inhibiting the hindleg flexor reflex in rabbits. Neuropharmacology 12, 111–121 (1973)
Villarreal, J.E., Sheldon, M.I., Smith, C.B.: Separation of the effects of dependence producing analgesics upon locomotor activity of mice and catecholamine synthesis in the brain. Pharmacologist 13, 313 (1971)
Vogt, M.: The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954)
Volavka, J., Zaks, A., Roubicek, J., Fink, M.: Electrographic effects of diacetylmorphine (heroin) and naloxone in man. Neuropharmacology 9, 587–593 (1970)
Wada, M., Tanaka, H., Hirano, T., Taneiti, Y.: The effect of morphine administration upon the output rate of epinephrine, blood sugar level and blood pressure in normal and tolerant dogs. Tôhoku J. exp. Med. 34, 52–71 (1938)
Wajda, I., Datta, K.: Effect of drugs on acetylcholine metabolism in the caudate nucleus of rats. Pharmacologist 13, 313 (1971)
Wand, P., Kuschinsky, K., Sontag, K.-H.: Morphine-induced muscular rigidity in rats. Europ. J. Pharmacol. 24, 189–193 (1973)
Watanabe, K., Matsui, Y., Iwata, H.: Enhancement of the analgesic effect of morphine by sodium diethylidithiocarbamate in rats. Experientia (Basel) 25, 950–951 (1969)
Wauquier, A., Niemegeers, C.J.E., Lal, H.: Differential antagonism by naloxone of inhibitory effects of haloperidol and morphine on brain self-stimulatio. Psychopharmacologia (Berl.) 37, 303–310 (1974)
Way, E.L., Loh, H.H., Shen, F.-H.: Morphine tolerance, physical dependence, and synthesis of brain 5-hydroxytryptamine. Science 162, 1290–1292 (1968)
Way, E.L., Loh, H.H., Shen, F.-H.: Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. exp. Ther. 167, 1–8 (1969)
Way, E.L., Sung, C.Y., Fujimoto, J.M.: The effect of adrenalectomy on the development of tolerance to morphine and methadone. J. Pharmacol. exp. Ther. 110, 51–52 (1954)
Weber, H.: Ueber Anasthesie durch Adrenalin. Verh. dtsch. Kongr. inn. Med. 21, 616–619 (1904)
Wei, E.: Assessment of precipitated abstinence in morphine-dependent rats. Psychopharmacologia (Berl.) 28, 35–44 (1973a)
Wei, E.: Brain lesions attenuating “wet shake” behavior in morphine-abstinent rats. Life Sci. 12, 385–392 (1973b)
Wei, E.: Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. Brit. J. Pharmacol. 47, 693–699 (1973c)
Wei, E., Loh, H.H., Way, E.L.: Neuroanatomical correlates of morphine dependence. Science 177, 616–617 (1972)
Wei, E., Loh, H.H., Way, E.L.: Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. exp. Ther. 184, 398–403 (1973a)
Wei, E., Loh, H.H., Way, E.L.: Brain sites of precipitated abstinence in morphine-dependent rats. J. Pharmacol. exp. Ther. 185, 108–115 (1973b)
Weil-Malherbe, H., Smith, E.R.B., Eisenman, A.J., Fraser, H.F.: Plasma catecholamine levels and urinary excretion of catecholamines and metabolites in two human subjects during a cycle of morphine addiction and withdrawal. Biochem. Pharmacol. 14, 1621–1633 (1965)
Weinstock, M.: Acetylcholine and cholinesterase. In: Clouet, D.H. (Ed.): Narcotic drugs; Biochemical pharmacology, pp.254–261. New York: Plenum Press 1971
Weissman, A.: Cliff jumping in rats after intravenous treatment with apomorphine. Psychopharmacologia (Berl.) 21, 60–65 (1971)
Welsh, J.H.: 5-Hydroxytryptamine in coelenterates. Nature (Lond.) 186, 811–812 (1960)
Welsh, J.H., Moorhead, M.: The quantitative distribution of 5-hydroxytryptamine in the invertebrates, especially in their nervous systems. J. Neurochem. 6, 146–169 (1960)
Wikler, A.: Studies on the action of morphine on the central nervous system of cat. J. Pharmacol. exp. Ther. 80, 176–187 (1944)
Wikler, A.: Effects of morphine, nembutal, ether and eserine on two-neuron and multineuron reflexes in the cat. Proc. Soc. exp. Biol. (NY.) 58, 193–196 (1945)
Wikler, A.: Reactions of dogs without neocortex during cycles of addiction to morphine and methadone. Arch. Neurol. Psychiat. (Chic.) 67, 672–684 (1952)
Wikler, A.: Clinical and electroencephalographic studies on the effects of mescaline, N-allylnormorphine and morphine in man; A pharmacologic analysis of the functions of the spontaneous electrical activity of the cerebral cortex. J. nerv. ment. Dis. 120, 157–175 (1954)
Wikler, A.: On the nature of addiction and habituation. Brit. J. Addict. 57, 73–79 (1961)
Wikler, A.: Conditioning factors in opiate addiction and relapse. In: Wilner, D.M., Kassebaum, G.G.: Narcotics, pp. 85–100. New York: McGraw-Hill 1965
Wikler, A., Altschul, S.: Effects of methadone and morphine on the electroencephalogram of the dog. J. Pharmacol. exp. Ther. 98, 437–446 (1950)
Wikler, A., Carter, R.L.: Effects of single doses of N-allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction. J. Pharmacol. exp. Ther. 109, 92–101 (1953)
Wikler, A., Frank, K.: Hindlimb reflexes of chronic spinal dogs during cycles of addiction to morphine and methadon. J. Pharmacol. exp. Ther. 94, 382–400 (1948)
Wikler, A., Green, P.C., Smith, H.D., Pescor, F.T.: Use of a benzimidazole derivative with morphine-like properties orally as a presumptive reinforcer in conditioning of drug seeking behavior in rats. Fed. Proc. 19, 22 (1960)
Wikler, A., Martin, W.R., Pescor, F.T., Eades, C.G.: Factors regulating oral consumption of an opioid (etonitazene) by morphine-addicted rats. Psychopharmacologia (Berl.) 5, 55–76 (1963)
Wikler, A., Norrell, H., Miller, D.: Limbic system and opioid addiction in the rat. Exp. Neurol. 34, 543–557 (1972)
Wikler, A., Pescor, F.T.: Persistence of “relapse-tendencies” of rats previously made physically dependent on morphine. Psychopharmacologia (Berl.) 16, 375–384 (1970)
Wikler, A., Pescor, M.J., Kalbaugh, E.P., Angelucci, R.J.: Effects of frontal lobotomy on the morphine-abstinence syndrome in man; an experimental study. Arch. Neurol. Psychiat. (Chic.) 67, 510–521 (1952)
Wikler, A., Rayport, M.: Lower limb reflexes of a “chronic spinal” man in cycles of morphine and methadone addiction. Arch. Neurol. Psychiat. (Chicago) 71, 160–170 (1954)
Wolff, H.G., Hardy, J.D., Goodell, H.: Studies on pain. Measurement of the effect of morphine, codeine and other opiates on the pain threshold and an analysis of their relation to the pain experience. J. clin. Invest. 19, 659–680 (1940)
World Health Organization: Expert Committee on Drugs Liable to Produce Addiction; Report on the Second Session. Wld Hlth Org. techn. Rep. Ser. 21, 1950
Yaksh, T.L., Yamamura, H.I.: The effect of morphine in vivo on resting and evoked release of 3Hacetylcholine from the cat caudate nucleus. Pharmacologist 15, 203 (1973)
Yarbrough, G.G., Buxbaum, D.M., Bushing, J.A., Sanders-Bush, E.: Effect of acute and chronic morphine sulfate administration on brain serotonin (5HT) synthesis in rats and mice. Pharmacologist 12, 211 (1970)
Yarbrough, G.G., Buxbaum, D.M., Sanders-Bush, E.: The role of serotonin (5-HT) in morphine locomotor effects in the rat. Pharmacologist 13, 314 (1971)
Yarbrough, G.G., Buxbaum, D.M., Sanders-Bush, E.: Increased serotonin turnover in acutely morphine-treated mice. Biochem. Pharmacol. 21, 2667–2669 (1972)
Yarbrough, G.G., Buxbaum, D.M., Sanders-Bush, E.: Biogenic amines and narcotic effects. II. Serotonin turnover in the rat after acute and chronic morphine administration. J. Pharmacol. exp. Ther. 185, 328–335 (1973)
Yeh, S.Y., Mitchell, C.L.: Potentiation and reduction of the analgesia of morphine in the rat by pargyline. J. Pharmacol. exp. Ther. 179, 642–651 (1971)
York, J.L., Maynert, E.W.: Role of analgesimetric procedure in assessing effects of chronic deficits of brain catecholamines or serotonin. Pharmacologist 15, 242 (1973)
Yunger, L.M., Harvey, J.A.: Effect of lesions in the medial forebrain bundle on three measures of pain sensitivity and noise-elicited startle. J. comp. physiol. Pharmacol. 83, 173–183 (1973)
Zaks, A.M., Bruner, A., Fink M., Freedman, A.M.: Intravenous diacetylmorphine (heroin) in studies of opiate dependence. Dis. nerv. Syst.-GWAN Suppl. 30, 89–92 (1969)
Zetler, G.: Substanz P, ein Polypeptid aus Darm und Gehirn mit depressiven, hyperalgetischen und morphin-antagonistischen Wirkungen auf das Zentralnervensystem. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 228, 513–518 (1956a)
Zetler, G.: Wirkungsunterschied zwischen den Polypeptiden Bradykinin und Substanz P am Zentralnervensystem. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 229, 148–151 (1956b)
Zetler, G., Schafii-Laschteneschai, A.-H., Jacobsen, F.G.: Die Hemmung der Morphin-, Levorphan-, Methadon-und Pethidin-Analgesie der Maus durch “spezifische” und “unspezifische” Antagonisten. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 246, 191–202 (1963)
Zimmermann, E., Krivoy, W.: Antagonism between morphine and the polypeptides ACTH, ACTH1-24, and β-MSH in the nervous system. In: Zimmermann, E., Gispen, W.H., Marks, B.H., De Wied, D.: Progress in Brain Research-vol. 39, Drug Effects on Neuroendocrine Regulation. Amsterdam: Elsevier Scientific Publishing Company 1973
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Martin, W.R., Sloan, J.W. (1977). Neuropharmacology and Neurochemistry of Subjective Effects, Analgesia, Tolerance, and Dependence Produced by Narcotic Analgesics. In: Martin, W.R. (eds) Drug Addiction I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 45 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66612-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-66612-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66614-8
Online ISBN: 978-3-642-66612-4
eBook Packages: Springer Book Archive